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TO MY WIFE AND PARENTS,
Summary
Prostaglandin biosynthesis by decidual and myométrial micros
somes from pregnant rat uteri was investigated by incubation with 
r 141I I'- C -arachidonic acid. Arachidonic acid metabolites synthesized 
by these preparations were separated and identified using TLC 
procedures. The optimal incubation conditions for maximum biosyn­
thesis were determined.
The influence of hydroquinone, GSH, L-cysteine and EDTA, used 
as cofactors in microsomal incubations, on overall prostaglandin 
synthesis was examined. The effect of SH group containing cofactors 
on the ratio of prostaglandins synthesized was also investigated.
The effect on prostaglandin biosynthesis by decidual and 
myométrial microsomes of replacing hydroquinone with other possible 
'natural' cofactors was inspected. Of particular interest were 
biogenic amines such as adrenaline and noradrenaline, which have 
been postulated as possible endogenous cofactors.
The influence of the day of pregnancy on prostaglandin synthesis 
by decidual and myométrial microsomes was examined with respect to 
the quantity and type of prostaglandins synthesized. It was found 
between days 13-22 of pregnancy that prostaglandin biosynthesis 
increased as pregnancy progressed. Maximum prostaglandin synthesis 
was observed on day 22 of pregnancy - expected day of delivery. 
Synthesis declined sharply one day post-partum.
The incubation of decidual and myométrial microsomal suspensions 
with a selection of non-steroidal anti-inflammatory drugs showed that 
uterine prostaglandin synthetase was inhibited by these drugs and did 
not differ radically from the inhibition of other prostaglandin
synthetases. However, when inhibited by tranylcypromine or 
metopirone there was no preferential inhibition of one particular 
prostaglandin as seen by other workers. The most potent drug 
tested was flurbiprofen.
An inhibitor of arachidonic acid metabolism by decidual and 
myométrial microsomes was found in the microsomal supernatant of 
decidual, myométrial and placental microsomes. The inhibitor was 
found to be heat labile, inhibited'in a dose dependent manner, and , 
was not due to metabolism of prostaglandins, with the site of action 
at the cyclo-oxygenase.
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Goldblatt (1933, 1935) and Von Euler (1935, 1937) investigating 
independently human seminal plasma and extracts of sheep seminal ves­
icular glands discovered a novel substance having both vasodepressor 
and smooth muscle stimulating activity. As it was found in extracts 
of both prostate and vesicular glands Von Euler (1935) named the 
principle prostaglandin. Initial characterisation established it to 
have the properties of a fatty acid, being easily extracted with 
lipid solvents from an acidic aqueous solution, also freely soluble 
in aqueous alkali. Further characterisation was hindered by the lack 
of appropriate techniques, but a little later it was shown that 
prostaglandin was nitrogen free, probably being unsaturated and con­
taining hydrophilic groups. Its purification was aided by the 
preparation of a soluble barium salt. Von Euler (1939) concluded 
that prostaglandin was a lipid soluble fatty acid probably containing 
a double bond and a hydroxy group.
New techniques developed during the 1950's provided effective 
new methods for purification and separation; chromatography playing 
a major role. Bergstrom and Sjoval (1957) isolated one prostaglandin 
'factor' (PGF) in crystalline form. In 1960 this was followed by the 
isolation and preliminary x-ray crystallography for prostaglandins F 
and E (Bergstrom and Sjovall, 1960a,b). This firmly established 
prostaglandins not as a single compound but a group of chemically 
related compounds, all derivatives of a parent substance, prostanoic 
acid, which is not known to occur naturally.
After some resourceful work the structure of the various prosta­
glandins were elicited; confirmation was obtained using x-ray 
crystallography (Abrahamsson, Bergstrom and Samuelsson, 1962) and mass 
spectroscopy (Bergstrom, Ryhage, Samuelsson and Sjovall, 1963) still
one of the most useful and powerful techniques available today. In 
1964 the first biosynthesis of prostaglandins was achieved. Van Dorp, 
Beerthuis, Nugteren and Vorikeman (1964a) and independently Bergstrom, 
Danielsson, and Samuelsson (1964) published details of the synthesis 
of prostaglandin from arachidonic acid using sheep vesicular glands 
as a source of the enzyme. Details of the isolation and properties of 
intermediates in prostaglandin biosynthesis were published, independ­
ently by Nugteren and Hazelhof (1973) and Hamberg and Samuelsson 
(1973). The intermediates were later shown to be endoperoxides.
A few years later, while investigating arachidonic acid metabolism 
by washed human platelets, Hamberg, Svensson and Samuelsson (1975) 
found a new group of compunds also formed by the metabolism of 
arachidonic acid via the endoperoxide intermediates. Due to the new 
group of non-prostanoid compounds origin and structure they were named 
thromboxanes. This was shortly followed by Gryglewski, Bunting, 
Moncada, Flower and Vane (1976) announcing the discovery of another 
metabolite of the cyclic endoperoxides (now known as prostacyclin) 
which effectively antagonised the biological activity of the throm­
boxanes.
1.2 Chemistry
The prostaglandins (PGs) are unsaturated hydroxy-acids with a
five membered ring in a twenty carbon atom skeleton. Their structure
is based on a monocarboxylic acid given the trivial name prostanoic
acid, which is not known to be a naturally occurring substance. PG
series are designated by letter, e.g. PGE. Each series is differ-
yentiated by the position of v^ous functional groups or double bonds, 
usually occurring within the cyclopentane ring. PGG is unusual in 
having a hydroperoxy group at the C-15 position, all others possessing
Figure 1. Numbering System of Prostanoic acid and Chemical 






















a hydroxyl group in this position. Nine series have been isolated
to date from PGA to PGI inclusive.
The members of each series differ by the number of double bonds 
they possess in the side chains. The number of double bonds in the 
side chains being designated by a subscript numeral, e.g. PGE^, 
which has two double bonds in its side chains. PGs of the "1" series 
invariably have a double bond in the trans position, members
of the "2 " series have another cis double bond in the ® position. 
The "3" series possess yet another cis double bond in the A^^
position. In the F series of PGs an additional subscript refers to
whether the C-9 hydroxyl group is above (a) or below (3) the plane 
of the cyclopentane ring i.e. denotes isomeric form.
The "1" and "2" series are the major PGs found in biological 
systems. The degree of unsaturation being determined by the fatty 
acid precursor. The precursor for the "1" series is all cis-8,11, 
14,eicosatrienoic acid (dihomo-y-linolenic acid, DHLA) and the 
precursor for the "2" series is all cis-5,8,ll,14,eicosatetraenoic 
acid (arachidonic acid, AA).
Chemically the A series of PGs are dehydration products of the E 
type, with the C-11 hydroxyl group being removed and a A^°  ̂̂ double 
bond formed. The B type PG is an isomer of PGA, where the A^°  ̂̂ 
double bond is shifted via the position (PGC which is
relatively unstable) to the A® ^̂  positioh. The transformation of 
PGE into PGA or PGB is easily achieved by treating PGE with acid or 
base. Since PGA and PGB are chromophores with characteristic U.V. 
absorption maxima of 217 nm and 278 nm respectively, the transform­
ation of PGE into PGA or PGB can be used as a method of assaying 
PGE. However, as an assay it is relatively insensitive requiring
several ̂ .g of PGE (Bergstrom, Da,nielsson, Klenberg and Sammuelsson, 
1964).
PGE or PGD (which is an isomer of PGE with the C-9 keto and 
C-11 hydroxyl groups interchanged) is easily converted into PGF^ 
or PGFg by treatment with sodium hide* Conversion of the endo­
peroxides PGG and PGH is readily achieved with a reducing agent, e.g. 
treatment of PGGg and PGH^ with stannous chloride or triphenyl- 
phosphine yields PGF^^. The latest PG series to be discovered, PGI 
is a bicyclic system with a cyclopentane and furan ring. This is 
unstable and rapidly rearranges to 6-oxo-PGF^, (Johnson, Morton, 
Kinner, Gorman, McGuire, Sun, Whittaker, Bunting, Salmon, Moncada 
and Vane, 1976).
The thromboxanes (TX) are C^q unsaturated hydroxy-acids but 
unlike prostaglandins are not based on the prostanoic acid skeleton, 
although they are derived from the same fatty acid precursors. The 
thromboxanes have an oxane ring in place of the cyclopentane ring 
of the PGs, but with the hydroxyl group at C-15. There are two 
series, TXA and TXB, the same subscript conventions applying as 
with PG nomenclature. TXA has a bicyclic oxane-ox&tone ring system. 
This is unstable and when attacked by a nucleophile (e.g. water) 
yields the stable and inactive hemiacetal derivative TXB.
1.3 Biosynthesis of Prostaglandins
Arachidonic acid (AA) cannot be synthesized de_ novo by animal 
tissues, and linoleic acid is required as a precursor for its synthe­
sis, this is provided by the animals diet. When the AA is synthesised 
and stored it is only that AA stored in membrane phospholipid pools 
that is available for PG synthesis. Flower and Blackwell (1976)
8
incorporated -AA into guinea-pig spleen and identified
phospholipids as the only source of substrate for PG synthetase.
Lands and Samuelsson (1968) using a sheep seminal vesical prepar­
ation found that a phospholipid substrate was only effective if the ' 
fatty acid was cleaved off, freeing the AA. The biosynthesis of 
PGs from AA was first demonstrated using homogenates of sheep 
vesicular glands as a source of the PG synthetase (Van Dorp,
Beerthuis, Vorkeman, 1964a; Bergstrom, Danielsson and Samuelsson,
1964). The first microsomal preparation of PG synthetase was by 
Van Dorp, Beerthius, Nugteren and Vorkeman (1964b) , again using 
sheep vesicular glands as the source of PG synthetase. Figures 2 
and 3 show the biosynthesis of the 2 series of PGs and TXs from 
AA. This is the most studied pathway as AA is far more abundant 
than dihomo-Y“linoleic acid.
PG synthetase is an enzyme complex. The first part, the cyclo- 
oxygenase component converts AA into the cyclic endoperoxides PGGg 
and PGH^.' These can then be converted to the PG or TX required by 
the isomerase component (Nugteren, Beerthuis and Van Dorp, 1966; 
Hamberg and Samuelsson, 1967). This conversion can be divided into 
three distinct steps, (1 ) initial double bond oxygenation (cyclo- 
oxygenase) (Hamberg, Svensson, Wakabayashi and Samuelsson, 1974);
(2) formation of the 15-hydropefoxy group of PGG (peroxidase)
(O'Brien and Rahimtula, 1976) and (3) conversion of endoperoxides 
into PGs or TX (isomerase) (Nugteren and Hazelhof, 1973).
The initial step in the conversion of AA is the sterospecific 
removal of the L-hydrogen at C-13, followed by isomérisation of the 
1 1-cis double bond to 1 2 -trans with the simultaneous attachment of 
one molecule of oxygen at C-11. There then follows the attachment 
of further molecular oxygen at C-15, with the concerted reaction
Figure 2. Metabolism of Arachidonic Acid to PGGg and the alternate 
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in which there is formation of the C- 8 C-12 bond (ring closure) and 
attack at C-9 by the oxygen radical to form the cyclic endoperoxide 
PGGg. The peroxide at C-15 can then be degraded to a hydroxyl, 
yielding PGHg (see Fig. 4). The cyclo-oxygenase provides a single 
common precursor for PGE^ and PGF^^ (Wlodawer and Samuelsson, 1973). 
Present knowledge indicates that the cyclic endoperoxides are the 
common precursors of all PGs and TXs known to date.
The transformation of AA to PGs has been postulated to involve
a free radical mechanism (Samuelsson, 1967). Panganamala, Sharma,
Sprecher, Geer and Cornwall (1974) carried the idea further and
proposed that the enzymic breakdown of hydrogen peroxide generates
an .OH radical and this is required for the initial oxygenation.
In support of this Panganamala et al (1974) found that catalase
(which converts hydrogen peroxide to water and molecular oxygen)
inhibited PG synthetase. Thus the fact that PG biosynthesis is
stimulated by hydroquinone is possibly explained by the ability of
hydroquinone to generate hydrogen peroxide by a quinone-hydroquinone
cycle (Deamer, Heikkila, Panganamala, Cohen and Cornwall, 1971).
2+Also the stimulation of PG biosynthesis by Fe enzyme complexes
e.g., haemin, haemoglobin (Yoshimoto, Ito and Tomita, 1970) may be
2+explained by the ability of Fe complexes to catalyse the decomp- 
ostion of hydrogen peroxide and generate .OH radicals. There has 
been an alternative mechanism proposed (Rahimtula and O'Brien, 1976) 
involving a peroxidase mechanism in which a singlet oxygen metal 
complex reacts with AA to form an unconjugated hydroperoxide. The 
hydroperoxide further reacts with the peroxidase part of the PG 
synthetase to form a peroxy radical which could then form the cyclic 
endoperoxide by a two step cyclization reaction.
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The pivotal substances in the synthetic pathway are the cyclic 
endoperoxides, PGGg, and PGHg (t^ approximately 5 min, Needleman, 
Moncada, Bunting^ Vane, Hamberg and gamuelsson, 1976) which may 
be modified into a diversity of products by the isoraerase component 
of the PG synthetase complex. They may also spontaneously degrade 
to give PGE^, PGD 2 and PGFg^ (Sun, 1977). Enzymically, via the 
isomerase component the cyclic endoperoxides may yield PGE^ or PGDg 
(by removal of the C-9 hydrogen atom or the C-11 hydrogen atom from 
the endoperoxide bridge respectively); reductive cleavage will yield 
PGFg^. A hydroxy fatty acid (12-hydroxy-5,8 ,10-heptadecatrienoic 
acid, HHT) and malondialdehyde (MDA) can also be formed from the 
PGHg by cleavage of a carbon-carbon bond. However, these products 
are of minor importance as they are thought to be formed by non- 
enzymic thermal degradation (Pace-Asciak, 1977). Until recently the 
significant active end products of the cyclic endoperoxides formed 
by the isomerase component were thought to be PGE^, PGDg and PGF^^.
But now TX synthetase, the predominant metabolic route in human 
platelets for AA has been identified (Hamberg, Svensson and 
Samuelsson, 1975; Needleman, Moncada, Bunting , Vane, Hamberg , 
and Samuelsson, 1976). This enzyme converts the cyclic endoper­
oxides to TXA^, a potent aggregating agent th approximately 30 sec, 
(Needleman, et al, 1976) that rapidly degrades to TXB^, an inactive 
substance.
More recently another synthetase has been found in arterial walls, 
and stomach fundus, known as prostacyclin synthetase which converts 
the cyclic endoperoxides to PGlg a highly active anti-aggregatory 
agent which spontaneously decomposes {th approximately 3 minutes. 
Dusting, Moncada and Vane, 1978) to an inactive metabolite, 6-0 x0 - 
PGF^^ (Johnson, Morton, Kinner, Gorman, McGuire, Sun, Whittaker,
17
Bunting, Salmon, Moncada, and Vane, 1976) .
AA can be metabolised by alternative pathways from PG 
synthetase, i.e. by lipoxygenase. This enzyme converts AA to 12- 
hydroperoxy-5,8,10,14-eicosatetraenoic acid (HPETE) and 12-hydroxy- 
5,8,10,14,eicosatetraenoic acid (HETE). Such conversion is usually 
small. As yet the biochemical properties of lipoxygenase have not 
yet been fully elucidated and the importance of these products is 
difficult to assess.
Purification of PG synthetase: The microsomal cell fraction was
chosen as a starting point for the purification of PG synthetase.
The microsomal fraction has the advantages that most of the endo­
genous substrate and the PG metabolising enzymes remain in the micro-
r 14 1somal supernatant. Therefore, exogenous substrate (e.g. I I -  Cj 
-AA) is not diluted and the products are not metabolised. After 
solubilisation of the PG synthetase with a non-ionic detergent 
(e.g. Tween 20, Samuelsson, 1970) an attempt was made to isolate the 
individual members of the PG synthetase complex obtained from bovine 
seminal vesicles (Miyamoto, Yamamoto and Hayaishi, 1974). Using a 
DEAE-cellulose column, two fractions were obtained fraction I, which 
(in the presence of tryptophan and haemoglobin) carried out the cyclo- 
oxygenase and peroxide functions of PG synthetase. Fraction II 
carried out the isomerase function on the product of fraction I, 
utilizing reduced glutathione (GSH) as a co-factor. Fraction I was 
found to have a molecular weight of 300-350,000 by gel filtration 
(Miyamato, Ogino, Yamamoto and Hayaishi, 1976).
Roth, Stamford and Majerus (1975) used j^acetyl - aspirin
to label the cyclo-oxygenase and estimated the molecular weight by 
gel-electrophoresis. Using sheep and bovine seminal vesicles micro-
18
somes and human platelet mfcrosomes a source of the cyclQ-pxygenase 
the mglecular weight was shown to be 85,000. A later study on sheep 
vesicular gland microsomes by Van Der Oudraa, Buyterhek, Nugteren 
and Van Dorp (1972) found that the molecular weight of the cyclo- 
oxygenase was between 72, and 85,000, but that in Tween 20 it behaved 
as a dimer. This may account for the high molecular weight found by 
Miyamoto et al (1974).
Cofactor Reguirements: Samuelsson (1967) first demonstrated that the
Production of PCs by sheep seminal vesicle microsomes were markedly 
stimulated by a heat stable cofactor(s) in the microsomal supernatants. 
This cofactor(s) could be replaced by exogenous cofactors in vitro 
because a specific stimulation was also achieved with GSH and anti­
oxidants such as hydroquinone and propylgallate (Nugteren, Beerthuis 
and Van Dorp, 1966). As microsomes are used to generate PGs and the 
cofactors are contained in the supernatant it is usual practice to 
add cofactors exogenously. Examples are GSH and hydroquinone or 
adrenaline which supply the reducing equivalents required by PG or TX 
synthetase. GSH may be one of the natural cofactorefor some synthetase 
systems as several other thiol compounds failed to stimulate PG bio­
synthesis (Van Dorp, 1967). However, it must also be taken into 
account that some systems appear to function without GSH. Cottee, 
Flower, Moncada, Salmon and Vane, (1977) found that ram seminal vesicle 
microsomes incubated in the presence of GSH produced a decrease in
6-oxo-PGF, formation and an increase in PGE_ formation. In the la 2.
absence of GSH only 6- o x o - P G F w a s  formed. GSH may be required by 
the PGE isometase component of the enzyme, or alternatively may act 
non-enzymica,lly directly on the cyclic endoperoxides. Lee and Lands 
(1972) showed that a copper-dithiol complex would facilitate the form­
ation of PGF over PGE, perhaps by supplying the cyclic endoperoxide 
with a source of electrons.
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It has also been shown that haem compounds (e.g. haemoglobin, 
myoglobin and haemin) stimulate PG biosynthesis. Yoshimoto, I to 
and Tomita (1970) concluded that haem compounds and hydroquinone 
were involved in the attachment of molecular oxygen to the fatty 
acid substrate whereas GSH was utilized for the reduction of the 
cyclic endoperoxide. However, Sih, Takeguchi and Foss (1970) 
proposed that GSH supplies reducing equivalents for the reduction of 
the oxidized hydroquinone, perhaps via an enzymic mechanism.
Another cofactor to be considered is L-tryptophan, proposed to 
stimulate formation of the cyclic endoperoxides in the presence of 
haem (Miyamoto, Yamamoto and Hayaishi, 1974), the cyclo-oxygenase 
requiring both cofactors for synthesis. The system used also 
required GSH for conversion of the cyclo-oxygenase into PGE or PGF.
Control of PG Biosynthesis: It has been found that there is little
free fatty acid substrate available for PG synthetase to utilize. 
Furthermore, PGs are not stored in cells as the dog spleen contains 
less than lyg of PGs but can release lOyg in the first minute after 
stimulation (Piper and Vane, 1971). Samuelsson (1972) postulated 
that control of PG biosynthesis could be achieved by controlling the 
access of the substrate to the PG synthetase. This would enable 
humoral or neuronal stimuli to act as a trigger for PG biosynthesis. 
Flower and Blackwell (1975) confirmed that the phopholipids are the 
source of AA for PG synthetase. Therefore, the release of AA by 
phospholipase A^ is the rate limiting step in PG production (Bosisio, 
Galli, Galli, Nicosia, Spangnuolo, and Tosi, 1976).
There are two possible mechanisms by which phospholipase A 2 may 
be activated. The first is by control of free calcium ions since 
plesma membrane and microsomal phospholipase activity is totally
20
dependent on the presence of free calcium ions (Newkirk and Waite,
1973). It is phospholipase from these sources that is implicated 
in cleaning the substrate required by the PG synthetase (Vogt, 1978). 
Several substances which increase PG production are known to enhance 
calcium ion penetration of cell (e.g. catecholamines). The second 
mechanism of control of phospholipase A^ activity may depend on 
access of the enzyme to the phospholipid, which is affected by the 
structural arrangement of the phospholipid in the bilayer membrane 
(Verger, Rietsch, Van Dam-Mieras and De Haass, 1976). It has been 
claimed that the incorporation of foreign molecules into a membrane 
(e.g. local anaesthetics in low concentrations) will enhance 
membrane phospholipid cleavage, and increase PG synthesis (Vogt, 
1978). It is possible that a stimulant (e.g. hormone) interacting 
with a receptor may change the permeability of the membrane to 
phospholipase A^.
1.4 Metabolism of Prostaglandins
With the introduction of tritiated PGs it was possible to follow 
the metabolic fate of PGs vivo. The most important step for bio­
logical inactivation is the oxidation of the hydroxyl group at C-15. 
The enzyme responsible for this is PG 15-hydroxy dehydrogenase (PGDH) 
and gives rise to the 15-keto PG. This metabolite can be further 
metabolised by reduction of the double bond by PG reductase.
This is then followed by both a 3 and o) oxidation. The enzymes PGDH 
and PG A/ ̂ reductase are both found in the soluble cytoplasmic m : 
fraction of tissue hpmogenates and both require NADH as a cofactor.
It has been shown that the substrate for PG A^^ reductase must 
previously haye ha,d the C-15 hydroxyl group oxidised to activate the 
double bond (Samuelsson, Granstrom, Green and Hamberg, 1971).
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There is a difference in the end product of PG metabolism 
between species (normally occurring after the PGDH and PG 
reductase step). But, the prime sites for the metabolism of cir­
culating PGs in the bloodstream for all species are the lung and 
liver. It has been shown that a single passage through the lungs 
of a cat, dog, or rabbit caused a 90-95% loss of the biological 
potency of PGs and a single circulation thhough the liver caused a 
70-93% loss (Ferreira and Vane, 1967).
Reproductive tissue has a well documented ability to metabolise 
PGs, employing predominantly PGDH and PG A ̂ ̂ reductase to deactive 
PGs (Keirse and Turnbull, 1975). Virtually all uterine tissues 
appear to have some metabolic capacity, which is particularly high 
in foetal membranes and placenta, followed by the myometrium and 
decidua, while only low activity has been detected in the umbilical 
cord and none has been demonstrated in either amniotic fluid or 
umbilical venous blood (Keirse, 1978). It has also been demon­
strated that in rabbits during pregnancy there is a marked increase 
in PGDH activity in the rabbit lung (Egerton-Vernon and Bedwani,
1975). Blackwell, Flower and Vane (1975) showed that PGDH was a 
short-lived enzyme, by easily diminishing the ability of the kidney 
and lung to metabolise PGs with one dose of a protein synthetase 
inhibitor. They also postulated that PGDH synthesis may be con­
trolled by steroid or hormone factors circulating in the blood stream. 
Bedwani and M&rley (1975) had already shown that in rabbits 
progesterone treatment enhanced PGDH activity. Blackwell and Flower 
(1976) went on to show that hydrocortisone hemisuccinate and dexa- 
methasone could reduce PGDH activity in adrenalectomized rats, and 
further postulated that the decrease in PGDH levels seen at parturi­
tion could be due to the oestrogen surge which occurs approximately 
that time.
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Apart from PGs being deactivated by metabolism there are 
enzymes which will convert one active PG into another. A series 
of conversions occur in serum, PGE to PGA by a dehydrogenase followed 
by conversion of PGA to PGG by PGA isomerase, and finally conversion 
of PGG to PGB via PGG isomerase (Polet and Levine, 1975). The 
conversion of PGE to PGF has been demonstrated in the cytoplasmic 
fraction of guinea-pig liver (Hamberg and Israelsson, 1970) and 
sheeps blood (Hensby, 1974a). Transformation of PGDg to PGF2^ by 
a PG-ll-keto-reductase has also been reported (Hensby, 1974b).
There is a report of conversion of PGF2^ to PGE2 in rat kidney by 
PG-9-hydroxydehydrogenase (Pace-Asciak, 1975). Finally there is 
the possibility of non-enzymic conversion, normally to inactive 
metabolites i.e. degradation of TXA2 to TXB2 , or degradation of 
PGI2 to 6-oxo-PGF(although iĵ  vivo it is suggested these substances 
are substrates for PGDH, McGuire and Sun, 1978). The ability of 
PGs to undergo non-enzymic conversion must be considered especially 
during extraction procedures. The major example being the con­
troversy over the possibility that PGA detected in renal medulla 
homogenates may have been a degradation product of PGE created by the 
isolation and extraction procedure (Frolich, Sweetman, Garr,
Hallifield and Oates, 1975).
1.5 Measurement of Prostaglandins
There are two approaches to the measurement of PGs in biological 
samples. The first is to extract the endogenous PGs present and 
assay them by one of the accepted techniques. However, the quahtities 
extracted are normally low. Flower and McGlure (1975) state that 
generally quantities are between 0.1-lygy^, At these concentrations 
spect roscopic and optical techniques are not sufficiently 
sensitive, and cofactors, may also interferewith measurement
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depending on absorption maxima at particular wavelengths,
A much used technique of estimation is bioa,ssay, using a super­
fused cascade with suitable tissues (Gilmore, Vane and Wyllie, 1968). 
This method provides adequate sensitivity and with the use of anta­
gonists can be rendered selective. However, this system cannot be 
used to detect metabolites of active PGs as these have little 
activity. Bioassay is useful for detecting labile substances like 
TXA^ and PGIg, which are easily assayed directly after release from 
a tissue.
Radioimmunoassay is probably the most sensitive technique, with 
a threshold of 10-15 pg (Bauminger, Zor and Lindner, 1973). This 
method is most suited to A, B or F type PGs as the chemical mani­
pulation required to attach PGE to its carrier protein can result 
in conversion to PGA. The PGA subsequently, in vivo can be iso- 
merised to PGB, producing a mixed antibody preparation. Another 
disadvantage is that radioimmunoassay measures the inhibition of 
the binding of a labelled antigen to antibody, and this inhibition 
can be caused by other factors than PGs, i.e. pH, ionic strength, 
protein concentration (Granstrom, 1978). Gas chromatography/mass 
spectroscopy techniques can deal with ng quantities but this requires 
careful dérivatisation, expensive equipment and experience to 
operate efficiently.
The alternative to measuring endogenous levels of PGs is to 
measure the PG synthesizing capacity of a tissue. The isolated 
tissue to be studied is firstly homogenised. If only a crude 
homogenate is prepared, there is the advantage that the endogenous 
cofactor(s) is present, but so is the endogenous substrate, usually 
an unknown quantity. If a microsomal preparation of the tissue is
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made then there is the disadvantage that the endogenous cofactor(s) 
have to be replaced by exogenous cofactors. However, this system has 
the advantage that the endogenous substrate and PG metabolising 
en%ymes are left in the microsomal supernatant. Therefore, a radio­
labelled substrate can be introduced to produce radiolabelled PGs 
which can be simply assayed by thin layer chromatographic techniques. 
Estimates of the PG synthetic capacity of a tissue may be more 
accurate if isolated tissue is used as it has been shown that damaged 
cells release PGs and can artifically elevate tissue levels (Piper 
and Vane, 1971; Williams, Sneddon and Harney, 1974).
1.6 The Inhibition of Prostaglandin Biosynthesis
Vane (1971) was the first to suggest that the anti-inflammatory, 
antipyretic, and analgesic properties of drugs such as aspirin and 
indomethacin (non-steroidal anti-inflammatory drugs, NSAID) was 
related to their ability to inhibit PG biosynthesis. That paper and 
those published with it (Smith and Willis, 1971; Ferreira, Moncada 
and Vane, 1971) paved the way for the explosion in PG research that 
followed.
NSAIDs appear to act on the cyclo-oxygenase component of prosta­
glandin synthetase. Vane (1971) showed that aspirin and indometh­
acin inhibited PG synthesis by guinea-pig lung homogenates in the 
presence of exogenous AA. Therefore, it is apparent that the site of 
action of NSAIDs is at a stage after the release of the free substrate 
It has also been shown that indomethacin will inhibit the formation 
of the cyclic endoperoxide precursors of PGs by bovine vesicular 
gland microsomes (Miyamoto, Ogino, Yamamoto and Hayaishi, 1976).
This leaves the cyclo-oxygenase as the site of action of NSAIDs.
The kinetics of PG synthetase inhibition by NSAIDs is complicated by
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NSAIDs being collection of d^ugs with similar actions rather than 
similar structures. While some NSAIDs are simple competative inhib­
itors, other also have a time dependant irreversible inhibitor 
component (Cushman and Cheung, 1975). The different NSAIDs may also 
have different sites of action on the cyclo-oxygenase. Using 
l^acetyl-^nj - aspirin it has been shown that aspirin will irreversibly 
acetylate a single protein, probably at the active site of the cyclo- 
oxygenase, (Roth, Stanford and Majerus, 1975). While ^2-^ —
indomethacin has been shown not to form a covalent link with the 
cyclo-oxygenase, implying that the inhibition is reversible (Stanford, 
Roth, Shen and Majerus, 1977). This could indicate that there is 
a secondary effect which irreversibly inactivates the synthetase, as 
it has. been shown in some preparations that indomethacin inhibition 
of PG synthetase is time-dependant and irreversible (Rome and Lands, 
1955; Smith and Lands, 1971).
It has been noted that PG synthetase preparations from some sources 
are more susceptible to inhibition by NSAIDs than from other sources: 
their biochemical profiles also differ (Flower and Vane, 1974). This 
could be due to PG synthetase existing as isoenzymes both in different 
tissues from the same animal and between species. For instance Flower 
and Vane (1972) found paracetamol was much more active against rabbit 
brain synthetase than dog spleen synthetase. Also PG synthetase 
prepared from different rabbit tissues exhibited differing sensitiv­
ities to the inhibitory effects of indomethacin (Bhattacherjee and 
Eakins, 1973). This lends itself to the idea that selective synthe­
tase inhibitors may be developed to act in specific tissues. Because 
of their opposing effects on blood vessels and platelet activity 
selective inhibitors of TXA^ and PGlg synthetase are being developed.
One such drug is imidazole which will inhibit the conversion of cyclic
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endoperoxides to TXA^ by platelets, while only affecting the cyclo- 
oxygenase at much higher concentrations than those required for its 
selective effect (Moncada, Bunting, Mullane, Thorogood and Vane, 1977). 
A similar inhibition has been noted for prostacyclin synthetase with 
15-hydro -peroxy arachidonic acid (Moncada, Gryglewski, Bunting 
and Vane, 1976). This may indicate that prostacyclin synthetase may 
be inhibited in vivo by lipid peroxides associated with altheroscle- . 
rosis and vitamin E deficiency (Moncada, Gryglewski, Bunting and 
Vane, 1976).
It must be noted that NSAIDs will not only inhibit PG biosynthesis 
but will also affect many other biological systems, indomethacin, for 
example will inhibit several proteolytic enzymes, histamine decarb­
oxylase, Mucopolysaccaride biosynthesis, uncouple oxidative phosphory­
lation, and stabilize serum proteins, erythrocytes, and lysosomal 
membranes. This list is not exhaustive, for a fuller exposition see 
Shen (1972), and Famaey, Brooks and Dick (1975). In general for 
effects on these systems a higher concentration of drug is required 
than that for inhibition of PG biosynthesis (Ferreira and Vane,
1974). While it can be demonstrated that sufficient concentrations 
of the drug can be found vivo for the realistic inhibiton of PG 
biosynthesis (Vane, 1974; Dembinska, Grodzinska and Piotrowiez, 1974).
There are other classes of compounds apart from NSAIDs that will 
inhibit PG biosynthesis. Some primary examples are given below. 
Anti-inflammatory corticosteroids have been postulated to work by 
stabilizing the cell membrane and preventing access of the phospholi­
pase A^ to the phospholipid (Hong and Levine, 1976). It now appears 
that both RNA and protein synthesis is required for inhibition of 
PG biosynthesis (Danon and Assouline, 1978) . So it may be that the 
corticosteroids generate a peptide which in turn stabilize the
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cellular membrane. Mepacrine, an anti-inflammatory and antimalarial 
agent is frequently used for inhibition of phospholipase activity 
thereby preventing release of substrate (Vargaftig and Hai, 1972).
Some psychotropic drugs (monoamine oxidase inhibitors and tri­
cyclic anti-depressents) have an inhibitory effect on prostaglandin 
biosynthesis. But this does not appear to be essential for their 
psychotropic effect (Lee, 1974; Krupp and Wesp, 1974; Kunze, Bohn, 
and Bahrke, 1975; Bekemeir, Giessler and Vogel, 1977). The 
mechanism of inhibition by psychotropic drugs is unknown.
Polyunsaturated fatty acids are another group of inhibitors.
Ziboh and co-workers (Ziboh, 1973; Ziboh, McElligatt and Hsia, 1973)
1
found that fatty acids such as linc^nic and eicosatrienoic acid ■
markedly inhibited PG synthesis by microsomal preparations of
human epidermis. Lands and co-workers (Lands, Le Tellier, Rome and
Vanderhoek, 1972; Vanderhoek and Lands,1973) found acetylenic fatty
acids potent inhibitors and postulated that they destroyed the
catalytic site of the cyclo-oxygenase and that the non-substrate
fatty acids may be released with the substrate (Lands, Le Tellier,
Rome and Vanderhoek, 1973). In the same paper they propose that the 
actual fatty acid substrates may cause self-catalysed destruction 
of the active site in the cyclo-oxygenase.
2+ 2+Some heavy metal ions have inhibitory activity. Zn , Cd ,
Cû "*" have been shown to be inhibitory in concentrations of 5 .10 ^M, \
but this can be partially reversed by GSH (Nugteren, Berthuis and 
Van Dorp, 1956).
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1.7 Prostaglandins and Uterine Function
(i) The non-pregnant uterus ; PGs have been identified in the
uterine tissue of many species, e.g. sheep (Wilson, Cenedella,
Butcher and Inskeep, 1971), guinea-pigs (Poyser, 1972), hamsters
(Saksena and Harper, 1972), rats (Saksena and Harper, 1972) and
human (Downie, Poyser and Wunderlich, 1974). In sheep the prinic^pal
uterine PG identified was PGF. with very small amounts of PGF, ,2a la
and E^ (Wilson et al, 1971). In the guinea-pig uterus PGFg^ 
was again the major metabolite detected, with PGE^ present in small 
quantities. In the rat both PGF^^ and PGE^ were again detected 
(Ham, Cirillo, Zanetti and Kuehl, 1975), again the quantity of PGFg^ 
being higher than PGE^. In curettings of human endometrium Downie 
et al (1974) found PGFg^ and PGE^/ with the quantities of PGFg^ 
being greater than that of PGE^ at all times throughout the cycle.
In the study of some of the above uterine tissues a variation 
in quantity of PGs was noted with the changes in the menstrual cycle, 
for instance Downie et al (1974) found in the human endometrium that 
the levels of PGs fluctuated during the menstrual cycle, increasing 
in stages as the cycle progressed. A similar rise in PGs was also 
noticed during the last few days of the quinea-pig oestrus cycle 
which coincided with increasing oestrogen and decreasing progesterone 
levels in ovarian venous blood (Blatchley, Donovan, Horton and 
Poyser, 1972).
This suggested PG synthesis may be under hormonal control. 
Further evidence has been provided by Ham et al (1975) who showed for 
the rat that maximum levels of PGF were at proestrus, when oestrogen 
levels are maximal, and that a similar maxima could be induced in 
ovariectomized rats with oestrqdial-173. It has also been shown
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that in ovariectomized rats oestra.dial-173 alone is sufficient to 
increase PG levels over untreated animals (Sharma and Garg, 1972). 
These results support the idea that PG synthesis is under hormonal 
control, and that oestrogen plays a prominent role in this control.
The role of the PGs in the uterus appears to be to induce
contractions. The principal effect of PGF_ (and PGF, ) in vitro2a l a --------
is to weakly stimulate uterine contractions in mid-cycle strips of 
human myometrium, more vigorously on strips taken late in the 
menstrual cycle (Bygdeman and Eliasson, 1963a; Pickles and Hall, 
1963). In̂  vitro PGE^ (also PGE^ and PGE^) normally cause a decrease 
in the frequency and amplitude of myométrial contractions 
(Bygdeman and Eliasson, 1963a), but if the myométrial strip is taken 
early or late in the cycle, then a slight stimulation can be 
evoked (Bygdeman and Eliasson, 1963b; Pickles and Hall, 1963).
In vivo PGF2^ retains its stimulatory effect on the uterus (Pickles, 
Hall, Clegg and Sullivan, 1966), while PGE2 vivo causes stim­
ulation of the non-pregnant uterus (Karim, Hillier, Somers and 
Toussell, 1971).
The finding of PGs in endometrial curettings led Pickles, Hall, 
Best and Smith (1965) to postulate that PGs synthesized by the endo­
metrium stimulate myométrial contractions which result in the 
sloughing off the endometrium. They further postulated that the 
ratio of PGF2^ to PGE2 may be crucial cind a disparity in the ratio 
may be the cause of dysmenorrhoea. This postulate has recently 
received support from Lundstrom and Green (1978) who compared endo­
genous levels of PGF2^ and its main metabolites in normal and 
dysmenorrhoeic women and found the PG levels were higher in 
dysmenorrhoeic women during menstruation. They also reported the
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successful treatment of dysmenorrhoeic symptoms with NSAIDs. This 
supports the concept that increased PG synthesis accompanied by 
increased uterine activity is the major pathological mechanism 
of dysmenorrhoea.
Evidence is accumulating that PGFg^ may be the luteolytic factor 
for some species, e.g. sheep (Chamley, Buckmaster, Cain, Cerini,
Cerini, Cumming and Coding, 1972); horse (Douglas and Ginther, 1972); 
cows (Lauderdale, 1972); and rodent (Labhsetwar, 1974). In the 
primates however, PGF^^ does not appear to be the luteolytic substance. 
It has been suggested that for the human there may be no luteolytic 
factor, as in hysterectomized women the menstrual cycle persists 
(Pharris and Shaw, 1974). It must be noted that décidualization 
occurs as a normal part of the menstrual cycle in humans, while in 
many species it occur only on of the ova. Thus in
species where décidualization is a regular part of the cycle it is 
probable that menstruation occurs as a result of hormone changes 
initiated by luteal regression.
(ii) Prostaglandins and the pregnant uterus: In vitro it has
been found that E and F type PGs promote contractions in strips of 
pregnant human myometrium (Embrey and Morrison, 1969). It was soon 
found that PGEg or PGF^^ given intravenously stimulated uterine con­
tractions (Embrey, 1969). In fact PGE , PGE , PGF and PGF areX zL XUb
all able to stimulate the myometrium during all stages of pregnancy
PGEg being more potent than PGF2^. The quantities of both required 
to initiate contractions early in the pregnancy being 5-10 times
higher tha,n at term. There is strong evidence that PGs play a
significant role in parturition. Several studies using PG synthetase 
inhibitors (e.g. aspirin and indomethacin) have shown that it is 
possible to inhibit contractions of pregnant rat uteri in vitro
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(Vane and Williams, 1973); delay parturition and prolong labour in 
rats (Aiken, 1972; Chester, Dukes, Slater and Walpole, 1972); 
rabbits (Hertelendy, 1973); monkeys (Noyy, Cook and Mavough, 1974) 
and humans (Lewis and Schulman, 1973). Furthermore indomethacin 
can delay premature labour,(Zuckerman, Reiss and Rubinstein, 1974). 
While if the PG precursor AA is administered intra-amniotically it 
will initiate uterine contraction and promote abortion (Macdonald, 
Schultz and Duenhoelter, 1974).
The mechanism of the release of PGs at parturition is still 
unknown. It was thought at first, on finding the fall in 
progesterone and the concommitant rise in oestrogen levels that 
parturition was triggered by the alteration of oestrogen - progest­
erone ratio (Robson, 1933). However, it was shown that additional 
exogenous oestrogen did not promote abortion if administered to 
the pregnant rabbit (Schofield, 1962). Csapo put forward the 
idea that uterine activity was suppressed by progesterone, with the 
level of progesterone rising to cope with the lowering threshold 
for uterine stimulation (Csapo, 1956; 1975). Thus it is the pro­
gesterone withdrawal that precipitates parturition. Recently it has 
been shown in pregnant sheep that a temporary decline in progesterone 
levels is sufficient to initiate parturition (Mitchell and Flint, 1977) 
It is thought there is local control over parturition (Mitchell, Keirse, 
Anderson and Turnbull, 1976) and that the foetus may play a role in 
it (Parnham, Sneddon and Williams, 1975). It has been postulated that 
the release of a corticosteroid may trigger the drop in progesterone 
and rise in oestrogen levels, followed by rising prostaglanding levels. 
This is based on the results of Liggins, Grieves, Kendall and Knox 
(1972) who showed that infusion of dexamethasone in pregnant sheep 
caused an increase in PGF^^ levels and onset of labour.
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Because of their ability to instigate uterine contractions at 
any time during pregnancy PGs are now exstensively used for abortion 
during the second and third trimester of pregnancy, and induction of 
labour at term. Because PGs are rapidly metabolised analogues are 
being or have been developed, the most successful so far is 15- 
methyl-PGF^^. These agents tend to be used only for induction of 
abortions, as it is not known if their prolonged action may harm the 
foetus, if used to induce labour (Thiery and Amy, 1977). The 
mechanism appears to be a direct stimulation of the myometrium 
rather than acting on the progesterone levels (Pharris and Shaw, 1974).
Other methods of abortion also appear to involve PGs. Abortion 
induced by hypertonic saline administration is found to increase the 
concentration of PGF^^ (Gustavii and Green, 1972). It is proposed 
that the saline introduced into the amniotic sac causes decidual cell 
damage, and as mentioned earlier (see section 1.5) damaged cells 
release PGs. The released PGs would stimulate uterine contractions 
and expel the uterine contents (Gustavii and Brunk, 1972). Abortion 
can also be induced by distension with physiological saline (Csapo, 
1973). If the uterus of a post-partum rabbit is distended situ 
mechanically by a ballon there is an increase in uterine contractions 
during application of the stimulus. The increase in uterine activity 
was associated with an increase in PGF equivalents released into the 
uterine venous blood (Csapo, 1973). The PG level as well as uterine 
activity decreased on removal of the stimulus. It has been shown that 
if a tissue is distorted then PGs are released (Piper and Vane, 1971). 
It ha,s a,lso been proposed that in spontaneous abortion PGs are 
responsible for the increase in uterine activity, Karim and Hillier,
(1970) found PGFg^ and PGE^ present in amniotic fluid during spon­
taneous abortion, but no PGs were present if pregnancy was terminated 
surgically.
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Recently the myometrium has been shown to synthesize significant 
amounts of prostacyclin, but fts physiological role fs unknown. One 
function suggested has been to ensure a sufficient blood supply to 
the foetus (Williams, Dembinska-Kiec, Zmuda and Gryglewski, 1978), 
as PGlg is a potent vasodilator.
Thus it appears that uterine PGs may play two roles in pregnancy 
as shown by the fact indomethacin treated animals have a longer 
gestation period and a prolonged labour. Delay of parturition and 
lengthening of gestation is probably due to the drug preventing 
uterine PG synthesis which may prevent the luteolytic action of the 
PGs, and prevent withdrawal of the progesterone block (Fuchs, Smitasiri 
and Chantharaksri, 1976) although this probably does not apply to 
primates where PGs are not luteolytic and rhesus monkeys administered 
indomethacin from day 150 until delivery showed no significant 
elevation of progesterone levels (Nbvy, 1978). A second hypothesis 
is that the uterus does not become responsive to oxytocin unless 
sensitized by PG first (Schulman, 1977) the synthesis of which is 
prevented by the indomethacin. Prolongation of labour can be 
explained by the indomethacin preventing the large increase in PG 
synthesis seen at the time of delivery (Thorburn, Nicol, Bassett,
Schutt and Cox, 1972) which contributes to the increased uterine 
activity. There are discrepancies between ^  vitro and vivo 
studies, for instance Fuchs has shown that administration of 
indomethacin to pregnant rats near term did not inhibit uterine 
contractility in vivo (Fuchs, Smitasiri and Chantharaksri, 1976).
Despite this paradox the studies utilizing PG biosynthesis and 
contractility in the pregnant rat uterus vitro have provided a 
rational basis for the use of PG synthetase inhibitors to control 
uterine motility in the human in vivo. This is evidenced by the
34
fact that from these experiments indomethacin has been used to delay 
premature labour (Zuckerman, Reiss, and Rubinstein, 1974); women 
taking aspirin show extended pregnancy and period of labour (Lewis 
and Schulman, 1973).
Despite the physiological and clinical importance of uterine PG 
synthetase, particularly in parturition there is little information 
available concerning the uterine prostaglandin synthetase system 
or factors affecting it. Such a study is of essential importance 
and particularly in view of the fact that the potency of PG synthetase 
inhibition by a given aspirin-like drug varies widely between tissues 
(Dembinska-Kiec, Grodzinska and Piotronicz, 1974).
1 .8 Aims of this Study
1. To determine optimal conditions for AA metabolism by 
microsomal preparations of decidual and myométrial tissue 
from pregnant rat uteri.
2. To identify the PG-like products generated by decidual and
r 1 4 1myométrial microsomes from exogenous 11- Cl -AA.
3. To study the effect of different cofactors on production of 
PGs by decidual and myométrial microsomes.
4. To investigate the influence of the stage of pregnancy on 
AA metabolism by uterine microsomes.
5. To investigate the effect of non-steroidal anti-inflammatory 
drugs on PG biosynthesis by decidual and myométrial 
microsomes.
6 . To investigate the metabolism of PGs by the decidual and 






A variety of techniques are available for the identification 
and quantitation of PGs. Some of the most prominent techniques have 
been discussed in Chapter I (Section 1.5). The choice of assay 
usually decided on is a compromise between accuracy, sensitivity, 
specificity and cost.
As this study was an examination of the PG synthetase present in 
uterine tissue rather than a measurement of endogenous PG formation, 
a radiometric assay was to be employed. This would involve the 
incubation of PG synthetase preparations of uterine tissue with a 
radiolabelled substrate; extraction of products and unconverted 
substrate; separation by chromatographic techniques and quantitation 
of the products by liquid scintillation counting.
For this study it was found that the ^1-^^cJ -AA available 
had a sufficient specific activity to detect the labelled products.
2.2, Materials
Reagents and solvents were purchased from BDH Chemicals Ltd. , 
Poole, or the Sigma Chemical Company, London. Where possible they 
were of analar grade. Radiochemicals were obtained from the 
Radiochemical Centre, Amersham, these were:-
-arachidonic acid specific activity 60mCi/mmol 
1^5,6 (n)-^I^ -prostaglandin specific activity 60Ci/mmol
^5,6,8,11,12,14,15,(n)-^Hj -prostaglandin F^^ specific
activity 120Ci/mmol.
The l^l-^^-cJ -AA was made up to IpCi/ml in redistilled benzene 
and stored in dark sealed ampoules under nitrogen at 4*̂ C. Unlabelled 
AA (grade 1 from porcine liver) stock solutions were also prepared
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in redistilled benzene at concentrations of lOmg/mi and O.lmg/ml. 
These were again stored in dark sealed ampoules, but at -20°C. When 
AA was required for use the benzene was evaporated under nitrogen 
at 3 7 0c, and the AA redissolved in 30-50yl of absolute alcohol.
This was then diluted to the required concentration (so that the 
concentration of alcohol did not exceed 1%) with tris buffer (pH 8.0, 
O.lM) containing sucrose (0.25M), hydroquinone (0.5mM), GSH (2mM), 
EDTA (ImM), L-cysteine hydrochloride (ImM). This buffer was used 
routinely throughout this study for the incubation of uterine 
microsomal preparations. The tritiated PGs were made up in an 
ethanol/water solution (7:3) at a concentration of lOyCi/ml and 
stored in sealed ampoules at -2QOC. When needed aliquots were 
diluted with the above buffer to the required concentration.
PPO and dimethyl POPOP were supplied by Koch-Light Laboratories, 
Colnbrook. Initially the scintillant used was 0.5% PPO, and 0.03% 
dimethyl POPOP in toluene but this was shortly changed to 0.3% PPO, 
0.02% dimethyl POPOP in xylene/triton X114, (3:1), a cheaper, more 
efficient and versatile scintillant.
The prostaglandin standards PGA^, PGD^f PGE^ and PGF^^ were 
gifts from Dr. J. Pike of the Upjohn Company, Kalamazoo, U.S.A.
The pentane-acetone powder of ram seminal vesicle (RSV) was a gift 
from Dr. R.J. Flower of the Wellcome Research Laboratories,
Beckenham, England.
The following drugs which were used in this study were gifts 
from the manufacturing company:-
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Drug Company





Indomethacin Merck, Sharp & Dohme
Meclofenamate Parke-Davis
5,8,11,14,Eicosatetraynoic Acid (TYA) Roche Ltd.
Tranylcypromine Smith, Kline & French
2.3 Methods
(i) Preparation of Decidual and Myométrial Microsomes: Female
rats (CYF or Wistar strain) were killed on day 22 of pregnancy, 
expected day of delivery (day 1 of pregnancy was counted as the day 
of finding the cervical plug). The uterus was dissected out and its 
contents removed, it was then cleaned and weighed. In later experi­
ments the myometrium lying under the placentae (MUP) was dissected out. 
The decidual and myométrial tissues were separated by scraping the 
luminal surface with a microscope slide (see Fig. 5) . The myometrium 
was reweighed and the decidual weight calculated from the differ­
ence. An average tissue distribution would be as follows (Average 
of 15 uteri); average uterine weight 3.541 g, average myométrial 
weight 2.826 g, average decidual weight 0.141 g, average MUP weight 
0.574 g. A 20% (w/v) homogena,te of each fraction was then prepared 
in ice-cold buffer (as given in Section 2.1) using an Ultra Turrax 
homogeniser (full speed for 15 seconds). The homogenates were then 
centrifuged at 3000g for 30 minutes to prepare a cell free supernatant. 
The microsomes were obtained from this by further centrifugation at
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Figure 5. The separation of decidua and myometrium. The top
photograph shows longtitudinal section through a rat 
uterus on day 22 of pregnancy. The upper decidual 
layer can be clearly distinguished from the lower myo­
métrial layer, itself divided into circular and long­
titudinal muscle layers. The bottom photograph shows 
the same uterus after the decidua has been removed 
by scraping with a microscope slide. It can be seen that 
this technique removes the vast majority of the decidua 
without contaminating it with myometrium.
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100,000 g for 60 minutes. A typical yield of microsomes for 
decidual and myométrial tissue would be 2.45 mg and 3.31 mg per 
gramme of uterine tissue (-MUP) respectivily.
(ii) Assay for PG/TX Synthetase and Extraction of Products: The 
microsomal pellet obtained from the above procedure was then resus­
pended in a fresh volume of buffer by ultrasonication (20KHz, 150W
Imli,
for 15 seconds) to give a protein concentration of 1-2 mg/ml^aliquots 
of the suspension were incubated, normally for 30 minutes with 1 ml 
of buffer containing arachidonic acid (99 nmoles) and 200 nCi of 
l^l-^^cj -arachidonic acid to give a total substrate concentration 
of 51 yM. The reaction was terminated by 0.25 ml of citric acid 
(2M) . Samples of the microsomal suspension boiled before incubation 
served as controls.
For incubation of microsomes with NSAIDs, aliquots of the drugs 
were added to the microsomal suspension to give the required 
concentration of drug and a volume of 1.9 ml. Each incubate was 
then preincubated for 5 minutes before addition of the AA substrate 
(in 0 . 1 ml).
The PG-like products and unconverted substrates were extracted 
from the acidified incubation mixture with diethyl ether (2x1.5 vol). 
This was reduced to dryness under nitrogen at 37°C. The extraction 
procedure was verified using radio-labelled PGF^^, PGE^ and AA.
(iii) Separation and Quantitation of PG-like Products: The 
above residues were redissolved in 40 yl of chloroform/methanol 
solution (1:1) and applied to a thin layer chromotography (TLC) plate 
(silica gel G, 0.25 mm thick), accompanied by authentic PG markers 
and AA. The TLC plate was then developed to 15 cm in chloroform/
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Figure 6 . Radiometric assay for the isolation and identification 
of PCs synthesized by decidual and myométrial fractions 
of pregnant rat uteri.
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Ut e r i n e Fr a c t i o n . 
(My o m e t r i u m or d e c i d u a )
Pr e p a r e 20% h o m o g e n a t e at 0°c 
IN 6.IM t r i s/a c e t a t e b u f f e r (pH 8)
CENTRIFUGE 3 0 0 0 G ,  3 0  MIN.
Su p e r n a t a n t Pe l l e t
DISCARDED 
CENTRIFUGE I O O ^ O O O g  6 0  MIN.
Su p e r n a t a n t
DISCARDED
Pe l l e t
Re s u s p e n d e d by u l t r a s o n i c a t i o n
Incubate aliquots with 2 0 0  n C i
a r a c h i d o n i c a c i d for 30 MIN. 
bo i l e d s a mples u s e d as c o n t r o l s
Acidify p H 4 with citric acid
Ex t r a c t w i t h 2 x 1,5 v o l . of 
d i e t h y l ether
Evaporate under N2
Apply to T L C  PLATE
45
methanol/acetic acid/water (90;9; 1;0,65). The markers were located 
with iodine vapour and the plate was then scanned for radioactivity 
(using a Bertold thin-layer scanner model LB2723). The radioactive 
zones in each lane corresponding to authentic PGs were then 
scraped off the plate into scintillation counting vials and eluted 
with 1 ml of methanol. 10 ml of scintillant was added and the 
radioactivity in each sample estimated using a liquid scintillation 
counter (Phillips Liquid Scintillation Analyser, Model 01). Since 
the final mixture of scintillant was heterogeneous, a quench 
correction curve based on a channels ratio was used to programme the 
calculator board in the counter which calculated the absolute 
activity (dpm). From the counts obtained it was possible to calculate 
the product formation (in pmol/min) from the expression below:
Product formed pmol/min =
% substrate converted x substrate concentration (pmol)
100 X time of incubation (minutes)
(ivj Characterisation of Prostaglandins from the Microsomal 
Synthetase : The prostaglandin-like products formed by incubation of
microsomal PG synthetase with  ̂1-^^cJ -AA were characterised by 
chromatographic techniques using authentic PG markers; chemical con­
version, and for the products of the decidual microsomes gas 
chromatography/mass spectrometry.
(a) Chromatographic Techniques: All chromatographs were
carried out in lagged tanks allowed to equilibrate for 30 
minutes before use. All TLC plates were silica gel G, 0.25 mm 
thick unless stated otherwise authentic markers were run with 
extracts. The PG markers were normally visualised with iodine 
vapour. This was unsuitable for silver nitrate impregnated plates 
in that case the markers were visualised with phosphomolybdic 
acid in ethanol.
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System 1. Chloroform/methanol/acetic acid/water (90:9:1: 
0.65) (Pace-Asciak, Motawska and Wolfe, 1970), This system was 
regularly used throughout the study for the separation of PG- 
like products from the unconverted substrate and any hydroxy 
fatty acids formed. It was also capable of adequately 
separating PGE^ from PGF^^.
System 2. Chloroform/methanol/acetic acid (80:10:10)
(Cottee, Flower, Moncada, Salmon, and Vane, 1977), used in 
conjunction with TLC plates impregnated with silver nitrate by 
spraying with a 5% silver nitrate solution in ethanol/water 
(7:3) .
System 3. The organic phase of ethyl acetate/iso-octane/ 
acetic acid/water (11:5:2:10) (Cottee, Flower, Moncada, Salmon, 
and Vane, 1977) . This system, with System 2 was used to separate 
PGE^ and 6-oxo-PGF^^, which co-chromatograph in System 1.
System 4. Diethyl ether/methanol/acetic acid (90:1:2) 
(Nugteren and Hazelhof, 1973). This system was used to separate 
PGEg from PGDg, which are not adequately separated by System 1.
System 5. Benzene/dioxan/acetic acid (20:20:1) used in 
conjunction with 5% silver nitrated TLC plates (Green and 
Samuelsson, 1964). This was used after the chemical conversion 
of PGE^ by sodium hydroxide and sodium borohydride to identify
(b) Chemical Conversion of ^1-^^CJ — PGE^: After the
initial development in System 1 the radioactive zone corresponding 
to PGE^ was scraped off the TLC plate into a sintered glass 
funnel and eluted with methanol. The filtrate was divided into
47
two parts and reduced to dryness under nitrogen at 37°C. To 
one portion 2 ml of sodium hydroxide (0.5M) was added, whirly- 
mixed and incubated for one hour at 37^C. The second portion 
was taken up in water (pH 8.0) and solid sodium borohydride 
(10 mg) added, whirlymixed and again incubated at 37°C for 
one hour. Both samples were then acidified to pH 2.5 with citric 
acid (2M) and extracted with diethyl ether (2 x 1.5 vol). After 
evaporation the extracts were applied to a TLC plate and developed 
in solvent System 5.
(c) Gas Chromatography/Mass Spectrometry: The actual gas
chromatography/mass spectrometry (GC/MS) and derivatisation was 
carried out by Drs' Dawson, Boot, Co.ckerill, Malien and Osborne 
at the Lily Research Centre, Windlesham, Surrey. A preparative 
synthesis using 30 mg of decidual microsomes was carried out 
using the method described above. After the extracts had been 
chromatographed on System 1 and scanned the zones of radioactivity 
were scraped off into separate sintered glass funnels and eluted 
with methanol. These samples were then sent to the Lily 
Research Centre. From each sample the methyl ester, methyl oxine 
and trimethyl silyl ether derivatives were prepared and the 
products identified by GC/MS. The products were also quantitated 
against derivatives of authentic PGF^^. The full experimental 
details have been published (Cockerill, Malien, Osborne, Boot 
and Dawson, 1977).
(y) Preparation of ^l-^'^C^ -6-oxo-PGF^^: The GC/MS analysis
identified 6-oxp-PGF^^ in one of the extracts which chromatographed 
with PGEg. Authentic ^1-^^C^ -6-oxo-PGF^^ was prepared from |^l-^^cj 
AA (Cottee, Flower, Moncada, Salmon and Vane, 1977). An acetone- 
pentane powder of ram seminal vesicles (10 mg) was incubated in 1 ml
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of Tris (0.05M, pH 7.5) with 0,5 yg of -AA (lOOjyCi) without
cofgctors at toom temperature. The incubation mixture was then 
extracted with diethyl ether (2 & 3 vol). The extracts were dried 
under nitrogen and applied to a TLC plate developed in System 3.
Three radioactive zones were found with Rf equivalent to authentic
5-oxo-PGF^^, (approximately 55%), PGE^ (approximately 25%) and AA 
(approximately 5%). The zone with a Rf equivalent to authentic
6-oxo-PGF, was eluted with methanol. A sample was then run on la
TLC System 2 and the Rf checked to see if it corresponded with the 
published Rf values for 6 - o x o - P G F T h e  rest was stored in methanol 
at -20°C.
(vi) Preparation of an Acetone-Pentane Dry Powder of Uterine 
Microsomes: This method was derived from that of Wallach and Daniels,
(1971) . The decidua and myometrium were separated as before but in 
potassium chloride (0.154 M) and the temperature kept between 0-3°C.
The two fractions were homogenised using an Ultra-Turrax (full speed 
15 seconds), and then centrifuged at 3000 g for 10 minutes. The 
supernatant was then filtered off through gauze. Acetone was then 
added slowly until it reached a concentration of 30%. The resulting 
precipitate was recovered by centrifugation, 3000 g for 15 minutes.
The precipitate was blended with approximately 15 volumes of 
acetone (w/v). This mixture was filtered on a chilled Buchner funnel 
using Whatman No: 4 paper. After removal of most of the solvent a 
rubber dam was stretched oyer the top of the funnel and the precipitate 
pressed until no further solyent could be removed. The precipitate 
was then quickly resuspended in approximately 7.5 volumes of acetone 
(w/y) and filtered as before. The precipitate was again resuspended, 
but this time in 5 volumes of pentane (w/v) . Most of the pentane was 
removed as before; the precipitate was transferred to a round-bottomed
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flask and the remaining pentane temgyed by eyapor^tipn yacuo.
When dry the precipitate was. transferred to a y^cuum desiccator 
oyer phosphorus pentoxide.
(yii) Concentration of Hydroquinone Replacement Cofactors : 
Adrenaline, noradrenaline, 5-hydroxytryptamine, histamine and 
L-tryptophan were used at a concentration of 0.5 mM, the same as 
that of hydroquinone. Haemoglobin, used in conjunction with 
L-tryptophan at a concentration of 0.75 yM. L-ascorbic acid at a 
concentration of 1 mM was used both to protect adrenaline and 
noradrenaline from auto-oxidation and as a cofactor. This con­
centration was selected as that concentration of L-ascorbic acid 
which would prevent formation of adrenochrome from adrenaline for 
at least two hours.
(viii) Qualitative Determination of PG Synthesis using 
Sodium Thiobarbiturate : This method was adapted from that of Flower,
Cheung and Cushman (1973). 2-Thiobarbituric acid (0.144 g) was 
suspended in 10 ml of water and sodium carbonate added (0.083 g in
6.5 ml of water) to give a 1% solution (w/v) of sodium thiobarb­
iturate. The uterine or RSV microsomes were incubated normally, 
the reaction being terminated with the addition of 0.1 ml of 100% 
trichloroacetic acid (w/v) in IN hydrochloric acid. 0.1 ml of 
sodium thiobarbiturate was then added and the mixture boiled for 
20 minutes. The resulting red colouration was clarified by centri­
fugation (3000 g for 10 minutes) and aliquots read at 532 nm. 
Incubation tubes which did not contain any microsomal enzyme 
preparation served as controls. This assay was used solely to 
determine whether PG synthesis occurred or not and no attempt at 
quantitation was made.
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(ix) Preparation qf NSA,ID Solutions; Solutions of these drugs 
were always freshly prepared before use. A stock solution of each 
drug (10  ̂ or 10  ̂M) in the normal tris buffer (pH 8.0) used for 
routine incubations, either with the aid of a small quantity of 
absolute ethanol (400 yl in 25 ml) or by using sodium carbonate to 
make the sodium salt.
(x) Protein Estimation: All protein estimations were determined
by the method of Lowr.ey, Rosenbrough. Far and Randell (1951) .





3.1 Validation of Extraction Procedure
The extraction of substrate and products from the acidified 
incubation medium by diethyl ether was investigated. 200 nCi of
-AA, [5 ,6 ,8 ,1 1 ,1 2 ,1 4 , 1 5 (n)-^Hj - PGFg^ and [5 ,6 , (n) -
- PGE^ were added to separate 2 ml aliquots of buffer as used for 
routine incubations. Then each aliquot was acidified and extracted 
with three portions of diethyl ether (1.5 vol). Each portion was 
separately evaporated under nitrogen in scintillation counting vials. 
Methanol (1 ml) was added and subsequently 10 ml of scintillant, the 
radioactivity was then estimated by scintillation counting. The 
percentage recovery was then calculated. Table 1 shows that for both 
the standard PGs and for AA more than 97% could be recovered in the 
first two extractions, the number of extractions employed routinely.
14 3 3Table 1. Recovery of C-AA, H-PGE^ and H-PGF^^ from acidified
suspensions of uterine microsomes by diethyl ether. Percent
recovery as percentage of original counts added.







92.2 ± 0.5 92.1 ± 0.3 84.0 ± 0.7
6.1 ± 0.2 7.0 ± 0.4 13.5 ± 0.6
0.7 ± 0.3 1.1 ± 0.2 2.6 ± 0.1
3.2 Metabolism of PGs by the Uterine Microsomal Suspension
The possibility that the microsomal suspensions may have con­
tained PG metabolising enzymes was investigated by adding tritiated 
PGE^ and PGF^^ in place of the [^1-^^C^ -AA normally added. The 
microsomal suspensions was then incubated for 30 minutes at 37°C and
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extracted as for AA incubates. TLC indicated that for the decidual
microsomes 93% and 96% of the radioactivity recovered had Rf values
corresponding to authentic PGE^ and PGF^^ respectivily, while for
the myometrium 94% and 96% of the radioactivity recovered had Rf
values corresponding to authentic PGE^ and PGF^^. There were no
other peaks of radioactivity seen with the extracts of the tritiated
PGF- incubates. However, with the extracts of the tritiated PGE. a 2a 1
small peak (3%) with an Rf of 0.3 was seen. This same peak was also 
detected when samples of tritiated PGE^ were applied directly to the 
TLC plate and it was concluded that there was an impurity present in 
the stock solution of tritiated PGE^.
Tritiated PGE^ was used in preference to PGE^ as the latter was 
not available with a sufficiently high specific activity.
3.3 Products Formed During Incubation of the Uterine Microsomes 
The initial chromatograph of the incubation products using 
solvent system 1 (chloroform/methanol/acetic acid/water, 90:9:1:0.65) 
showed the decidual and myométrial microsomes produced dissimilar 
products. A representative scan of a TLC of the decidual and myomét­
rial incubation products by a Bertold TLC scanner is shown in Fig. 8. 
The dark areas indicate zones of radioactivity, the difference in AA 
metabolism between decidual and myométrial microsomes is clearly 
visible. The radioactive zone with an Rf below that of authentic 
PGF2^ seen on the decidual scan was found to be non-prostanoid in 
nature by a subsequent GC/MS analysis. It could be found in both 
decidual and myométrial incubates, although it is not clear in the 
myométrial scan depicted. When the total product formation was 
estimated this zone of radioactivity, and that zone with an Rf 
corresponding to that of monohydroxy fatty acids (MHFA) were excluded.
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Figure 7. The distribution of radioactivity after incubation of
uterine microsomes with tritiated PGF^ and PGE . Plates2a 1
run in solvent system 1 (chloroform/methanol/acetic acid/ 
water, 90:9:1:0.65). The radioactivity in consecutive 
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Figure 8. A scanning radiochromatogram of two TLC plates run in 
solvent system 1 (chloroform/methanol/acetic acid/ 
water, 90:9:1:0.65). The upper plate contained extracts 
of myométrial incubates. The lower plate extracts of 
decidual incubates. The four product peaks for the 
decidual can be clearly seen, in contrast with the 
single peak of the myométrial. The radioactive zone 
just below the AA zone is due to monohydroxy fatty acids 
(MHFA). The zone below the authentic PGF^^ marker is an 
unknown, but GC/MS analysis indicated it was non- 
prostanoid in nature. It was therefore excluded, along 
with MHFAs when total product formation was assessed.
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Fig. 9 shows a histogram of the distribution of incubation products of 
decidual and myométrial microsomes, minus the boiled control values 
(to avoid a negative value for the unconverted AA that peak was 
omitted). The chromatogram of the extracts from the decidual incub­
ation revealed six major peaks, one with an Rf of 0.93 corresponded 
to authentic AA (omitted in Fig. 9) while a second had an Rf 
similar to that expected of MHFAs. (The MHFA marker was prepared 
from AA using soybean lipoxidase). The four remaining peaks had Rfs 
of 0.25 (peak A) corresponding to authentic PGF^^, 0.33 (peak B ) ,
0.43 (peak C) corresponding to authentic PGE^ and 0.48 (peak D). In 
contrast the chromatogram of the extracts from the myométrial incub­
ations showed only three peaks, again one with an Rf corresponding 
to authentic AA (omitted from Fig. 9), and a second with an Rf 
expected of MHFAs. The third peak has an Rf corresponding to that 
of authentic PGEg.
The zones of radioactivity corresponding to authentic PGE^ from
both decidual and myométrial incubations were scraped from the TLC
plates and reacted with sodium hydroxide or sodium borohydride.
Sodium hydroxide treatment produced a radiolabelled product with an
Rf corresponding to PGBg when run in solvent system 5 (benzene/dioxan/
acetic acid, 20:20:1, in conjunction with 5% silver nitrated plates).
The sodium borohydride treatment converted the PGE-like incubation
product to a compound with an Rf corresponding to that of authentic
PGF„ . In ret rospect when it was realised that 6-oxo-PGF^ was 2a ' la
present in the zones used, these reactions were repeated and the pro­
ducts run in solvent system 3 (the organic phase of ethyl acetate/ 
iso-octane/acetic acid/water, 11:5:2:10) which was designed to separate
6-oxo-PGF from other prostaglandins. This revealed that 6-oxo-PGF, la Id
was unaffected by sodium hydroxide treatment, but was converted by
5 9
Figure 9. Metabolism of -AA by decidual and myo­
métrial microsomes. The histograms show the distrib­
ution of radiolabel after the products of incubation 
were extraction from acidified solution with ether. 
After evaporation the products were run in a solvent 
system of chloroform/methanol/acetic acid/water 
(90:9:1:0.65). The radioactivity in consecutive 
0.5 cm zones of the sample and a boiled control were 
estimated. The histogram shows net d.p.m. i.e. test 
minus boiled control values. The broken line at the 
solvent front indicates far more unconverted AA in the 
boiled control sample, as this would have given a 
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Figure 10. Distribution of radioactivity seen after treatment of
the PGE zone with sodium hydroxide or sodium borohydride. 
the products formed from .these chemical reactions were 
extracted and developed in solvent system 5 (benzene/ 
dioxane/acetic acid, 20:20:1 on 5% silver nitrated 
plates). The plate was then divided into successive 
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sodium borohydride to a compound which had an Rf similiar to that
of PGF^ .2a
GC/MS analysis of the decidual product peaks A,B,C and D revealed 
that peak A was PGF^^, peak B was TxBg, peak C a mixture of PGE^ and 
6-oxo-PGF^^ and peak D was PGE^. It was decided to supplement the 
GC/MS data concerning peak C by assessing the relative proportions of 
the PGs within this peak and to carry out a further investigation on 
the myométrial peak of radioactivity which like peak C of decidual 
microsomes also had an Rf value corresponding to authentic PGE^. For 
this purpose two TLC solvent systems developed by Cottee, Flower, 
Moncada, Salmon and Vane (1977) were employed. For the sake of 
brevity these systems have been termed system 2 (chloroform/methanol/ 
acetic acid, 80:10:10, using 5% silver nitrated plates) and system 3 
(the organic phase of ethyl acetate/iso-octane/water/acetic acid 11: 
5:10:2). Extracts from the incubation media were first separated in 
solvent system 1. The peaks of radioactivity corresponding to PGE^ 
for both myométrial and decidual microsomes were then scraped off, 
the radioactivity eluted and rechromatographed in one or both of the 
systems described. The distribution of radioactivity seen using 
system 2 is shown in figure 11. For the decidual peak C this solvent 
system confirmed the presence of 6-oxo-PGF^^ (36.1 ± 2.5% of the 
radioactivity had a mobility corresponding to authentic 6-oxo-PGF^^, 
n = 13) although the majority of the radioactivity still had an Rf 
corresponding to PGEg (53.9 ± 4.0%, n = 13). In contrast this TLC 
system showed the majority of the radioactivity in the myométrial peak 
to have ^n Rf similar to authentic 6-oxo-PGF^^ (76.6 ± 2.0%, n = 13) 
with only a small quantity having an Rf corresponding to authentic 
PGE^ (11.6 ± 1.8%, n = 13), Similar results were obtained using sol­
vent system 3, the distribution of radioactivity is shown in Fig. 12.
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Figure 11. Thin-layer chromatogram of decidual peak C and myo­
métrial products peak from TLC system 1 rechromato­
graphed in solvent system 2 (chloroform/methanol/acetic 
acid, 80:10:10, using 5% silver nitrated plates). The 
plate was then partitioned into consecutive 1 cm zones 
and the radioactivity in each zone estimated. It can 
be seen that whereas in the decidual peak C the 
majority of the radioactivity has an Rf corresponding 
to authentic PGEg in the myométrial product peak the 
majority of the radioactivity has an Rf corresponding
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Figure 12. Spectrum of radioactivity after rechromatographing 
the peaks from decidual and myométrial incubations 
corresponding to PGEg in TLC system 1. The peaks of 
radioactivity were rerun in a solvent system com­
prising the organic phase of ethyl acetate/iso-octane/ 
water/acetic acid, 11: 5:10:2. (solvent system 3). The 
plate was divided into successive 1 cm zones and the 
radioactivity estimated. The major product in the 
decidual peak had an Rf corresponding to authentic 
PGE^, while in contrast the major product in the 
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This confirmed that the radioactivity in the myométrial peak 
consisted predominantly of material with an Rf corresponding to 
authentic 6-oxo-PGF^^ (80.4 ± 2.9%, n = 13) again with a small 
percentage with an Rf corresponding to authentic PGEg (10.5 ± 1.2%, 
n = 13). The finding for the decidual peak C also agreed with that 
found in the previous TLC system 50.8 ± 1.3% (n = 14) of the radio­
activity had an Rf corresponding to authentic PGEg and 36.8 ± 3.5%
(n = 14) had an Rf corresponding to authentic 6-oxo-PGF^^.
Decidual peak D was also subject to further investigation. The 
decidual incubation products were again separated in solvent system 
1, peak D was then scraped off and the radioactivity eluted and 
rechromatographed in a solvent system developed by Nugteren and 
Hazelhof (1973) (diethyl ether/methanol/acetic acid, 90:1:2) and for 
brevity termed solvent system 4. The distribution of radioactivity 
seen using this system is shown in Fig. 13. It revealed that 
45.6 ± 1.6% (n = 27) of the radioactivity present in the decidual peak 
D had no Rf corresponding to authentic PGEg, while 60.9 ± 1.1%
(n = 27) had an Rf corresponding to authentic
The proportions of each product synthesized by the decidual and 
myométrial microsomes is shown in Table 2, estimated by both GC/MS 
and TLC techniques for the decidua. It must be noted that there was 
an inevitable loss of radioactivity when products were separated in 
two TLC systems, since the products were expressed as a percentage 
of the total counts on the plate. However, this loss was relatively 
small and consistent, being for peak C 13.4 ± 1.2% (n = 27), for 
peak D 13.2 ± 1.3% (n = 26) and when estimating the overall composition 
of products formed for decidual and myométrial microsomes was
7.2 ± 1.1% (n = 27) and 11.5 ± 0.8 (n = 26).
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Figure 13. Distribution of radioactivity obtained when peak D of 
decidual products in system 1 was rechromatographed in 
solvent system 4 (diethyl ether/methanol/acetic acid, 
90:1:2). The radioactivity in consecutive 1 cm zones 
was then found. This revealed that the products 
associated with decidual peak D were approximately 
equally divided into material with Rfs corresponding 
to PGEg and authentic PGDg.
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Table 2 Proportions of each PG-like product synthesized during the
incubation of decidual and myométrial microsomal suspensions 
with -AA (expressed as % of the ^1-^^cJ -AA converted
to PG-like products).
Tissue % Composition of PG-like Products




17.8±1.1 12.8±2.8 37.4±3.0 15.Oil.5 10.711.3
Decidua 
estimated by 
GC/MS (1 expt. 
only)




0 0 10.9±1.0 78.511.8 0
The overall synthesis of PG-like products from ^1-^^cJ -AA, 
excluding MHFAs was, for the decidual microsomes 27.4 ± 1.4% or 
28.0 ± 1.4 nmol (n = 65), over 30 minutes. While that for the 
myométrial microsomes was 10.2 ± 0.7% or 10.5 ± 0.7 nmol (n = 65) 
over 30 minutes, a much lower conversion than seen with decidual
microsomes.
3.4 Incubation Conditions 
(i) pH:
The effects of pH on conversion of substrate to products was 
examined over the range pH 6.0-9.0, for both decidual and myométrial 
microsomes. The optimal pH in both cases was found to be pH 8.0 
(see Fig. 14). Either an increase or a decrease in pH from this 
optima advers | y affected substrate metabolism. The PG synthetase 
complex was more tolerant to an increase in pH (with a reduction of
7 2
Figure 14. The effect of alteration of pH on rate of total PG-like 
product formation by decidual (0-0) and myométrial 
(A-A) microsomes. All other incubation conditions 

















approximately 6%, in synthesis for both decidual and myométrial 
microsomes at pH 8.5). A decrease in pH of half a unit produced a 
much larger inhibition of product synthesis (at pH7.5 a 30% reduction 
in synthesis for both microsomal preparations was noted).
(ii) Incubation Time
Typical time courses of AA metabolism to PG-like products are
b
shown in Fig. 15. It can be seen that with decidual inci^tions 
nearly half the products are synthesized in the first 5 minutes. 
Substrate conversion continued at a steady rate for the next 25 mins. 
doubling the conversion seen at 5 minutes. This was paralleled in 
the myométrial microsomal preparation to a lesser degree. To obtain 
maximum PG production particularly for the myométrial microsomes 
where AA metabolism appears intrinsically low an incubation time of 
30 minutes was selected for routine incubations.
(iii) Protein Concentration
There did not appear to be a linear relationship between the pro­
tein concentration of the microsomal suspension and substrate 
conversion for either of the two uterine fractions over the range, 
0.7-5.7 mg for decidual microsomes and 0.9-8.1 mg for myométrial 
microsomes (see Fig. 16). Because there was no linear relationship, 
expression of product formation in terms of microsomal protein con­
centration was avoided. As far as possible within experiments, 
protein concentration was kept constant. In different experiments 
protein concentrations varied between approximately 0.75-2 mg per 
incubation.
(iv) Substrate Concentration
The effect of varying the substrate concentration upon product 
formation is shown in Fig. 17. For the decidual microsomes there 
was a linear increase in product formation between 10 yM-130 pM.
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Figure 15. Variation in AA conversion with time in decidual (0-0) 
and myométrial (A-A) incubations. It can be seen that 
nearly half of the decidual PG synthesis occurs in the 
first 5 minutes, conversion continued at a steady rate 
for the next 25 minutes, doubling that seen at 5 
minutes. This was paralleled in the myométrial micro­
somal incubations, which had a lower synthetic capacity 
than the decidual microsomes.
35
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However, above this value there was a sharp and progressive decrease 
(a 36% reduction at 250 yM). In comparison product formation by 
myométrial microsomes was at a much lower level over the range of 
substrate concentrations studied. It appeared to be maximal at 
51 yM of AA. Although much less pronounced, product formation by 
myométrial microsomes also declined after peaking at 51 yM with 
increasing AA concentrations. To achieve maximum conversion of the 
radiolabelled AA a substrate concentration of 51 yM was used 
routinely.
(v) Cofactors
Microsomal preparations have been found to give better yields 
of products if the incubation medium contains exogenous cofactors. 
The buffer used in this study contained hydroquinone, GSH and L- 
cysteine for this purpose.
(a) Hydroquinone; The initial experiments had been designed 
so that the microsomes were resuspended in hydroquinone-free 
buffer, after which aliquots were adjusted to the required 
hydroquinone concentration. However, it was found that if this 
procedure was followed then the enzyme preparations from both 
decidual and myométrial fractions were inactive. To obtain an 
active enzyme preparation it was critical for the hydroquinone 
to be present while the microsomes were resuspended.
Fig. 18 shows that with decidual microsomes maximal product 
conversion occurred at 0.5mM of hydroquinone. After product 
formation was adversely affected so that at 0.75mM there was a 
45% decrease in product formation. With myométrial microsomes 
variation in hydroquinone concentration had much less effect, 
giving an optimal range between 0.25-0.75mM. For routine
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Figure 18. The effect of increasing hydroquinone concentrations
on formation of PG-like products by decidual (0-0) and 
myométrial (A-A) microsomes. The optimal concentration 
for both tissue fractions was O.SmM of hydroquinone. 
Above this value there was considerable inhibition 
with decidual microsomes. The myométrial microsomes 
were also inhibited by concentrations of hydroquinone 
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assays a concentration of O.SmM of hydroquinone was used for 
both tissue fractions.
(b) GSH: The optimal concentration of GSH for maximum product 
formation by both microsomal preparations was 2mM. The absence 
of GSH from the incubation mixture did not prevent biosynthesis 
taking place, but reduced it by approximately 50% for both 
decidual and myométrial microsomes. Increasing the concentration 
of GSH above 2mM caused a decrease in product formation, 
reducing AA metabolism by decidual microsomes by 35% at 3mM, 
but myométrial synthesis was reduced by only 11% at 3mM GSH.
A concentration of 2mM GSH was used for both tissue fractions 
in routine assays.
(c) L-Cysteine: For the decidual microsomes there was a 
dramatic rise in product biosynthesis with the increase in L- 
cysteine concentration up to ImM, which was optimal. Bio­
synthesis increased by 60% between 0-lmM L-cysteine. At 1.5mM 
there was a 30% decrease in synthesis of products. The myométrial 
microsomes were much less affected by alterations in L-cysteine 
concentrations, having an optimum range between 0.5-1.5mM.
This increased the product formation by 17% at maximum over 
incubations without L-cysteine. In routine assays a concentration 
of ImM L-cysteine was used for both decidual and myométrial 
microsomes.
(d) The effect of SH containing Cofactors on Products formed: 
Owing to the possibility that the SH containing cofactors may 
have preferentially influenced the formation of one of the 
products synthesized by the microsomes it was decided to examine 
microsomal preparations of both tissue fractions in the presence
85
Figure 19. The effect of increasing GSH concentrations on PG-like
product formation by decidual (0-0) and myométrial (A-A) 
microsomes. The optimal concentration of GSH for 
decidual microsomes was 2mM, with marked reduction in 
synthesis of products if this concentration of GSH 
is increased or decreased. For myométrial microsomes 
the optimum GSH concentration was again 2mM. 
Concentrations of GSH above or below this did reduce 



















Figure 20. The effect of increasing concentrations of L-cysteine 
on the ability of decidual (0-0) and myométrial (A-A) 
microsomal preparations to synthesize PG-like products 
from AA. The optimal concentration for both decidual 
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Figure 21. The influence of GSH and L-cysteine on AA metolism 
by decidual microsomes. After the incubation the 
products were extracted and run using solvent system 
1 (chloroform/methanol/acetic acid/water, 90:9:1:0.65) 
For the purpose of liquid scintillation counting the 
plate was divided into 0-5 cm zones. In the top 
chromatograph the decidual microsomes were incubated 
with GSH and L-cysteine and PG synthesis was normal.
In the lower chromatograph GSH and L-cysteine were 
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Figure 22. The influence of GSH and L-cysteine on AA conversion
by myométrial microsomes. The extracts of the incubates 
were run in solvent system 1 (chloroform/methanol/ 
acetic acid/water, 90:9:1:0.65). The plates were then 
divided into 0.5 cm zones for the purpose of counting 
the radioactivity present. In the upper chromatograph 
the myométrial microsomes were incubated in the 
presence of GSH and L-cysteine. In the lower chromato­
graph GSH and L-cysteine were omitted from the 
incubation mixture. It can be seen that the absence 
of the two cofactors drastically lowered PG synthesis.
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And absence of the relevant cofactors. The results can be 
seen in Table 3. This shows no difference in the proportions 
of the PG-like products produced by either decidual or 
myométrial microsomes when incubated with SH containing 
cofactors, compared to microsomes incubated in the absence 
of SH containing cofactors.
e) EDTA: It was found that for decidual microsomes that the
addition of ImM EDTA increased substrate conversion by 50% 
compared to incubates without EDTA. Above ImM there was a 
slight decline in synthesis (7% reduction at 4mM). The effect 
of EDTA on myométrial microsomes was similar to that seen with 
decidual microsomes, but produced a 40% increase in synthesis 
when incubated with EDTA, and a decrease of 12.5% at 4mM EDTA.
For routine assays therefore, a ImM concentration of EDTA was 
used for both tissues.
vi) Storage of Decidual and Myométrial Microsomes: Initial
attempts to store suspensions of decidual and uterine micro­
somes involved freezing 1ml aliquots of the resuspended micro­
somes in buffer at -20°C. It can be seen from Fig. 24, that this 
was not satisfactory, approximately 65% of the activity for both 
suspension was lost when stored overnight.
An attempt to prepare an acetone-pentane powder by the method 
of Wallach and Daniels (1971) was also unsuccessful, the activity 
of the resulting preparation from decidual and myométrial 
homogenates being very low, approximately Inmole per 30 minutes 
incubation.
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Figure 23. The effect of increasing EDTA concentrations on the 
synthesis of PG-like products by decidual (0-0) and 
myométrial (A-A) microsomes from AA. The optima for 
both microsomal fractions was ImM, above this there was 
a slight decrease in PGs synthesized by both micro­
somal preparation. Below the optimal concentration 
of EDTA there was a sharp decrease in PG synthesis 
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Figure 24. The effect of storage of decidual (0-0) and myométrial 
(A-A) microsomes at -20°C, in 1ml aliquots and the 
subsequent effects on PG-like products synthesized 
from AA when thawed at various time intervals. The 
storage of microsomal fraction of decidual and myo­
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3.5 Replacement of Hydroqiiinone by Other Cofactors
It was decided to investigate the possibility of replacing 
hydroquinone by other cofactors, e.g. the biogenic amines, 
adrenaline, noradrenaline, 5-hydroxytryptamine, and histamine, also 
L-ascorbic acid and a combination of L-tryptophan and haemoglobin.
In several experiments with decidual and myométrial microsomes those 
peaks in the initial TLC with co-chromatographing components were 
scraped off, eluted, and rerun on the appropriate TLC system. The 
subsequent results reflected any change in the proportions of 
products synthesized.
Comparison of overall synthesis showed that for the decidual 
microsomes (Fig. 25) only 5-hydroxytryptamine could substitute 
equally for hydroquinone, with adrenaline and noradrenaline having 
about 50% of the stimulatory ability of hydroquinone. Histamine and 
the combination of L-tryptophan and haemoglobin proved particularly 
poor. L-ascorbic acid was better having approximately a quarter of 
the stimulatory activity of hydroquinone. In the case of myométrial 
microsomes (Fig. 26) using adrenaline, noradrenaline and 5-hydroxy­
tryptamine in place of hydroquinone produced a 33-93% increase in 
AA metabolism (but this was only significant for noradrenaline). 
Histamine and the L-tryptophan-haemoglobin combination were again 
poor as cofactors. L-ascorbic acid stimulated the myométrial micro­
somes surprisingly well, and was almost comparable to the stimulation 
obtained with hydroquinone.
With decidual microsomes an increase in the proportion of PGFg^ 
was seen with all cofactors compared to hydroquinone. Table 4. With
5-^hydroxytryptamine and histamine there was a slight decrease in TXB^
1 0 0
Figure 25. Ability of different cofactors to substitute for
hydroquinone as cofactor for AA metabolism in decidual 
microsomes. p Values are all relative to hydro­
quinone. * = p<0.05, ** = p<0.02, *** = p<0.0001.
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Figure 26. Ability of different cofactors to substitute for 
hydroquinone as a cofactor for AA metabolism in 
myométrial microsomes, p values are all relative to 
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formation as well. With myométrial microsomes the only significant 
change was seen with 5-hydroxytryptamine and histamine where there 
was a slight decrease in the percentage of 6-oxo-PGF^^ formed, but 
with no significant increase in PGE^ formation (Table 4). It must be 
noted that this may be due to losses incurred in the process of 
rechromatographing the product peaks, although this was consistant 
and low, in the order of 8.2 ± 1.2%, n = 39, for the decidua, and 
11.7 ±0.8%, n = 39 for the myometrium. Table 5, shows the contri­
bution which each AA metabolite made to the total PG-like products 
formed, in nmole, by decidual and myométrial microsomes.
3.6 Inhibition of Uterine PG Synthetase by Non-Steroidal Anti-
Inflammatory Drugs.
The results shown in Figs. 27 and 28 display the susceptibility 
of decidual and myométrial microsomal PG synthetase to a variety of 
non-steroidal anti-inflammatory drugs (NSAIDs). All NSAIDs were 
found to inhibit PG biosynthesis in a dose related manner for both 
preparations. The inhibition by NSAIDs was calculated from reduction 
in total product synthesized.
From the dose related inhibition of PG synthesis the dose of the 
drug which caused 50% inhibition (I.D.^^) was calculated graphically 
(see Table 6). This revealed that the most potent drug used was 
flurbiprofen, while the least potent was metopirone. From the I.D.^^s 
the relative potencies for the drugs were expressed on a molar basis 
relative to TYA for both decidual and myométrial preparations. The 
rank order of potency was found to be, in order of decreasing potency; 
flurbiprofen > meclofenamate > indomethacin > fenclozic acid > 
aspirin > alclofenac, for both decidual and myométrial PG synthetase.
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Figure 27. Inhibition of decidual PG synthetase in vitro by NSAIDs 
Each drug was preincubated for 5 minutes with the 
microsomal suspension, then incubated normally for 30 
minutes under routine conditions. Drugs used were; 
flurbiprofen ( ♦ - ♦ ) ,  meclofenamate ( 0 - 0 ) ,  indometh­
acin (A-A), TYA (•-•), tranylcypromine (A-A), aspirin 
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Figure 28. Inhibition of myométrial microsomal PG synthetase by
NSAIDs. Each drug was preincubated for 5 minutes with 
the microsomal suspension and then incubated under 
routine conditions for 30 minutes. Drugs used were ; 
flurbiprofen ( ♦ ” ♦)/ meclofenamate ( □ - □ ) ,  
indomethacin (A-A), TYA (#-#), tranyclypromine (A-A), 
aspirin ( ■ - ■ ) ,  alclofenac (<C>“0 ) /  and metopirone 
(0-0).
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Tr’̂ny 1 cypromine 1.62x10-4 2.73x10-4
Fenclozic Acid 8.41x10-4 5.62x10-4
Aspirin 2.13x10-3 7.89x10-4
Alclofenac 2.58x10-3 2.16x10-3
Metopirone 3x10-3,26.9% inhibition 3x10-3,39.6% inhibition
Table 7. Relative Molar potency of NSAIDs incubated with Uterine 
microsomes. TYA, is taken as 1.00.
Relative Molar Potency for 50% inhibition of











It was noticable from the dose response curves that the NSAIDs 
appear to be divided into two groups, flurbiprofen, meclofenamate, 
indomethacin and TYA in one group, and tranylcypromine, aspirin, 
fenclozic acid and alclofenac in the other. There is a break in the 
I.D.50 values between tranylcypromine and TYA, 20 fold for the 
decidual and 50 fold for the myometrium.
Tranylcypromine was examined to see if there was any preferential 
inhibition of the AA metabolites synthesized by the uterine micro­
somes, especially the myométrial microsomes, where there may have 
been the possibility of a preferential inhibition of PGIg and hence
6-oxo-PGF^ . But, it was found that the PGE^-6-oxo-PGF, ratio was la 2 la
-4unchanged at a concentration of 10 M tranylcypromine (which gave
42% inhibition), the proportion of each was 14.4 ± 3.2% PGE^ and
76.5 ± 5.3% 6-oxo-PGF^^. Metopirone primarily a steroid biosynthesis
inhibitor was also tried as a PG synthetase inhibitor, having been
reported to stimulate PGF^^ formation in crude homogenates of day
22 pregnant rat uteri (Parnham and Sneddon, 1975). However, with
decidual and myométrial microsomes it was found that metopitone was
a poor PG synthetase inhibitor, causing only 27% and 40% inhibition
of PG synthesis by decidual and myométrial microsomes respectively
-3with a dose of 3 x 10 M. The relative proportions of products also 
remained unchanged.
3.7 The Influence of the Day of Pregnancy on PG Biosynthesis
It was found that between days 13 to 19 pregnancy that myométrial 
microsomes produced considerably more PGs than decidual microsomes 
(Fig. 29), The quantity of PGs synthesized by decidual and myométrial 
microsomes was similar on days 20, 21 and 22 of pregnancy. The peak 
of myométrial PG synthetic activity was on days 19-22, and dropped
1 1 3
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sharply one day post partum. While the decidual microsomes synthetic 
ability peaked dramatically on day 22, increasing the quantity of PGs 
synthesized nearly threefold, which one day post partum was abolished 
returning to levels comparable to the synthetic capacity of myométrial 
microsomes.
In the case of the myométrial microsomes although there is an 
increase in the quantity of PG synthesized the relative proportions 
of each product remained practically unchanged. 6-oxo-PGF^^ was 
always found to be the major product constituting 76-85% of the total 
PGs synthesized. However, for decidual microsomes there was a 
considerable variation in the proportions of the different PGs 
synthesized (Table 8). Before day 21 of pregnancy 6-oxo-PGF^^ is 
the major product, not until day 21 does PGEg become the major 
product. The proportion of PGDg was fairly constant between 3-6% 
which rose to 9% on day 22 and decreased again one day post partum.
The proportion of TXB^ was fairly steady between days 13-19 of 
pregnancy being between 4-7%. This rose to between 11-13% on days 
20-22, and also decreased post-partum (5.5%). The proportion of 
PGFg^ fluctuated throughout the days of pregnancy studied, being 32% 
on day 13, 11% on day 17, increasing again to 27% on day 21, falling 
to 18% on day 22. However, even with these fluctations the quantity 
of PGFg^ synthesized on day 22 was 50% up on that synthesized by the 
decidua on day 21 (table 9). In general terms the synthesis of all 
products of AA metabolism by decidual microsomes increased as 
pregnancy progressed and decreased after parturition. Figure 30 shows 
the decidual C and D peaks and the myométrial product peak from 
solvent system 1 (chloroform/methanol/acetic acid/water, 90:9:1:0.65) 
rechromatographed in solvent system 3 (organic phase of ethyl acetate/ 
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Figure 30. Thin layer chromatograph of decidual peaks C and D 
(upper chromatograph) and myométrial product peak 
(lower chromatograph) from a TLC run in solvent 
system 1 (chloroform/methanol/acetic acid/water, 
90:9:1:0.65) rechromatographed in solvent system 3 
(organic phase of ethyl acefate/iso-octane/acetic 
acid/water, 11:5:2:10) to demonstrate the difference 
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difference in PG production by decidual microsomes on day 18 of 
pregnancy and compares it with myométrial PG synthesis on the same 
day.
3.8 Microsomal Preparation of Myometrium Lying Under the Placentae
(MUP) and Placentae
Mic^somal preparations of the MUP and the placentae themselves 
were investigated for their ability to synthesize PGs under routine 
conditions established for decidual and myométrial microsomes. This 
revealed that the MUP and the placentae had little ability to 
synthesize PGs from the exogenous substrate present in the incubation 
media (Fig. 31). Total PG synthesis by MUP was 1.63 ± 0.18% or 
1.66 ± 0.19 nmoles, (n = 24), for the placentae 0.60 ± 0.20% or
0-61 ± 0.20 nmoles, (n = 5), over 30 minutes. Because of the low 
conversion of substrate to PGs, MUP sites were removed before 
preparation of decidual and myométrial microsomes to avoid dilution 
of the active PG synthesizing microsomes.
3.9 The Effect of Microsomal Supernatants on AA metabolism by
Uterine Microsomes
It has long been khown that there is a heat stable endogenous 
cofactor(s) present in the microsomal supernatant (see introduction). 
Thus an investigation was carried out to see if this endogenous 
cofactor(s) could replace hydroquinone in the incubation medium. The 
experiments were performed in hydroquinone-free buffer, with the 
respective supernatants being added back to the decidual and 
myométrial microsomes before resuspension. Half of the supernatant 
had been previously boiled for 2 minutes. Control incubations with 
the normal buffer were also carried out. The results shown in
121
Figure 31. The PG synthesizing capacity of microsomal prep­
arations of various uterine tissues and placenta 
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Table 10 Inhibitory activity of decidual and myométrial microsomal 
supernatants on PG synthesis by uterine microsomes







Decidua 21.910.9 0.6310.01 3.810.4
Myometrium 9.410.8 0.4610.05 5.010.2
Table 10 indicate that the supernatants from the decidual and 
myométrial microsomes virtually abolished AA metabolism by their 
respective microsomes. Boiling of the supernatant samples before 
addition to the microsomes reversed this inhibition to some extent.
Further experiments were carried out under routine conditions 
i.e. the incubation mixtures containing hydroquinone and the micro­
somal supernatants were added in various volumes to the incubation 
mixture. The following combinations were tested, (1) addition of 
myométrial microsomal supernatant of myométrial microsomes (Fig. 32), 
(2) addition of decidual microsomal supernatant to decidual micro­
somes (Fig. 33), (3) addition of placental microsomal supernatant to 
both myométrial and decidual microsomes (Fig. 34). It was found with 
all three microsomal supernatants that there was a volume dependent 
inhibition of PG synthesis by decidual and myométrial microsomes. 
However, the degree of inhibition of PG synthesis caused by equivalent 
volumes of microsomal supernatants varied i.e. 100 yl of myométrial 
microsomal supernatant inhibited myométrial microsomes by 44%, while 
100 yl of decidual microsomal supernatant inhibited decidual micro­
somes by only 23% and 100 yl of placental microsomal supernatant 
inhibited myométrial and decidual microsomes by 48% and 45% respecti­
vely. This inhibitory activity was abolished if the supernatants 
were boiled for two minutes.
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Figure 34. The inhibition of decidual (0-0) and myométrial 
(A-A) PG synthetase by placental microsomal 
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To establish that the inhibition was not due simply to a 
dilution of the -AA with endogenous AA present in the
supernatant; the supernatants were passed through a short column 
of silicic acid (8 x 0.8 cm) under nitrogen with a small quantity 
of ^1-^^cj -AA as a marker. This showed that all but 10.2 ± 1.8%
(n = 11) of the labelled AA was retained on the column. This 
should have greatly reduced the quantity of endogenous AA present 
in the supernatants, but there was no noticable effect on the 
inhibitor activity. All supernatants were subsequently passed 
through silicic acid columns before being added to incubates.
Since the decidual, myométrial and placental microsomal 
supernatants prepared from rats on day 22 of pregnancy it was 
decided to try the myométrial microsomal supernatant from non­
pregnant rats (there was insufficient decidual tissue for a similar 
decidual supernatant preparation). The results shown in Figure 35 
revealed that the non-pregnant myométrial supernatant had some 
inhibitory activity on PG synthesis by both myométrial and decidual 
microsomes. With 400 yl of the supernatant there was a 40% and 65% 
inhibition of PG synthesis by myométrial and decidual microsomes 
respectivily, the myometrium appearing to be far leSs affected by 
this supernatant preparation.
3.10 Inhibition of PG Synthesis by Placental Microsomal Supernatant
Owing to the greater quantity of placental microsomal 
supernatant available this was chosen as the primary source of 
material for the continuation of this study. The effect of 400 yl 
of placental microsomal supernatant on AA metabolism by myométrial 
a,nd decidual microsomes is illustrated in Figures 36 and 37. It can 
be seen that PG synthesis is greatly reduced when compared to control
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Figure 35. Inhibition of decidual (0-0) and myométrial (A-A) 
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Figure 36.. The effect on AA. metabolism by myométrial microsomes 
when incubated with (1) 400 yl of placental micro­
somes supernatant (lower TLC), (2) 400 yl of boiled 
placental microsomal supernatant (upper TLC). TLC 
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Figure 37 The effect on PG synthesis by incubating decidual 
microsomal supernatant (lower TCL) compared to a 
standard incubation plus 400 yl of boiled placental 
microsomal supernatant (upper TLC). TLCs were 
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incubations with 400 yl of boiled placental microsomal supernatant.
It was found that apart from boiling, the inhibitory activity of the 
placental microsomal supernatant disappeared if stored overnight 
at room temperature, 0°C, or -20°C. A lyophylate was therefore 
successfully prepared for long term storage and ready availability 
of the supernatant. The supernatant was lyophylised in a variety of 
buffers, phosphate buffer (pH 8.0 and pH 7.4), Krebs and tris (O.IM, 
pH 8.0). None of these buffers appeared to affect the activity of 
the reconstituted supernatant. Tris buffer was regularly 
used as it was nearer the buffer the uterine microsomes were 
incubated in.Controls incubated with the required volume of tris 
buffer (50-400 yl) showed that this addition had little effect on 
the PG production by uterine microsomes. The final volume was kept 
at 2.0 ml for all incubations. A mean concentration for the lyophylate 
in tris buffer was 15.3 ± 1.8 mg/ml, (n = 5) calculated from the 
original volume, with a mean protein concentration of 4.26 ± 0.76 mg/ 
ml, (n = 5). When it was used it was resuspended to the original 
microsomal supernatant volume.
The lyophylised placental supernatant was checked for inhibitory 
activity against ram seminal vesicle microsomes (RSVM). Initially 
using the thiobarbiturate assay, but the red colouration of the 
placental microsomal supernatant interferred with this. The radio- 
metric assay was, however suitable. Control synthesis of PCs by 
the RSVM was 60.9 ± 2.0%. when the RSVM were incubated with 400 yl 
of the reconstituted placental supernatant (in a final volume of 2 ml) 
41.2 ± 4.2% (n = 8) of the ^1-^^cj - AA was converted to PGs. This 
was a significant decrease, p<0.001 and indicated a 32% inhibition 
of RSVM.
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The pla cetal microsomal supernatant was also incubated with 
tritiated PGFg^ and PGE^ to check that there was no degradation of 
freshly synthesized PGs. This procedure produced no evidence of 
metabolites of PGs, 94% and 97% of the radioactivity recovered had 
identical Rfs to tritiated PGFg^ and PGE^ applied directly to the TLC 
plate. To gain an idea of the log dose relationship of the 
placental microsomal lyophylates one batch was prepared in distilled 
water (pH, 8.0) and a percentage inhibition v log dose graph 
constructed using the dry weight of the lyophylate (Fig. 38). This 
was similar to figure 34, where percentage inhibition was plotted 
against the log of the volume of placental microsomal supernatant, 
however, in this case the myométrial microsomes were much more 
affected than decidual microsomes, 2 mg of the lyophylate inhibited 
myométrial PG synthesis by 66%, but decidual PG synthesis by only 29%.
The effect of the placental supernatant on the proportions of 
PGs synthesized by the decidual and myométrial microsomes was 
examined (Table 11). This revealed there was no significant differ­
ence in the proportions of any of the AA metabolites synthesized 
by the decidual and myométrial microsomes when they were incubated 
with any volume of placental microsomal supernatant between 50-400 yl.
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Figure 38. The inhibition of decidual (0-0) and myométrial (A-A) 
microsomal PG synthesis by a lyophylised preparation 
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Arachidonic Acid Metabolism by Uterine Microsomes
The isolated pregnant rat uterus has been shown to release PGs 
into the bathing fluid, and this release increases as parturition 
approaches (Vane and Williams, 1973). Further it was found that 
cell free homogenates of decidua and myometrium were capable of 
synthesizing PGs from exogenous AA, with the majority of activity 
being found in decidual homogenates (Williams, Sneddon and Harney,
1974). Therefore in this study microsomes of decidual and myometrium 
tissue taken on day 22 (day of delivery) were studied. The exact 
location of the PG synthetase within the microsomal pellet was not 
investigated. However, Bohman and Larsson (1975) using a rabbit 
renal medullary microsome preparation found the majority of PG 
synthetase activity associated with the cytomembrane fraction, 
which consists of closed vesicles of smooth and r.ibosomal studded 
membranes. They concluded that the PG synthetase is located in the 
endoplasmic reticulum of renal medullary cells.
This study confirmed that the decidua has a more active PG 
synthetase than that of the myometrium, metabolizing three times 
more AA than the myometrium in a 30 minute incubation. It has been 
established by TLC techniques that the products of the myométrial PG 
synthetase is mainly 6-oxo-PGF^^ (77%) accompanied by a small 
proportion of PGE^ (10.5%). However, the PG synthetase in the 
decidual microsomes synthesizes a wider variety of products; the major 
product being PGEg (37.4%), followed by PGFg^ (17.8%), 6-oxo-PGF^^ 
(15%), TXBg (12.8%) and PGD^ (10.7%). These are the products 
detected and values obtained using TLC techniques. GC/MS analysis 
confirmed these findings except for the presence of PGDg. The lack 
of the major ions associated with PGDg was unclear. However, analysis 
was only conducted for one experiment, PGD^ was consistently isolated 
by chromatographic procedures.
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Attempts were made to establish the presence of PGEg in the
products of microsomal incubations by chemical conversion. Products
of microsomal incubations which had Rf values corresponding to
authentic PGE^ were treated with sodium hydroxide or sodium boro-
hydride, such treatment converts PGEg to PGBg or a mixture of
PGFg^ and PGFgg respectively (Sih and Takeguchi, 1973). While these
conversions were successful much of the original labelled product
did not extract from the acidified aqueous phase. As later
experiments revealed that peak C was a mixture of PGEg and 6-oxo-
PGF this may have accounted for this unexpected observation, la
Indeed authentic 6-oxo-PGF, was found to be unaffected by sodiumla ^
hydroxide. However, it was reduced by sodium borohydride treatment.
This is of interest as Pace-Asciak (1976) found that if the same
reaction was carried out in methanol at room temperature 6-oxo-
PGF, was found to be unreactive. However, in these studies water la
at 37°C was used as the solvent and it is probable that was 
facilitated by this, water having a well known hydrogen bonding 
ability and able to stabilise both cations and anions more 
effectively than methanol.
Incubation Conditions
When investigating influence of pH on PG production maximum 
conversion occurred at pH 8.0 for both decidual and myométrial 
microsomes. Although this is slightly alkaline many other 
microsomal tissues have been shown to have a pH optima close to 
this value, i.e. sheep seminal vesicle microsomes. pH 8.0, 
(Wallach and Daniels, 1971); bovine seminal vesicle microsomes 
pH 7.8-8.2, (Flower, Cheung and Cushman, 1973); rheumatoid 
synovial microsomes pH 8.0 (Crook and Collins, 1975), and reprod­
uctive tract microsomes of the house cricket pH 8.0 (Deslephano,
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Brady and Woodall, 1976). Rabbit kidney medulla microsomes have 
been shown to have pH optima between pH 7.5-8.3 (Blackwell, Flower 
and Vane, 1975b; Tai, Tai and Hollander, 1976; Schwartzman, Gafni 
and Raz, 1976) . For the uterine microsomes it was found there was 
a considerable decrease in substrate conversion as the pH decreased 
and if the assay had been carried out at physiological pH (i.e. 7.4) 
then there would have been a 30% reduction in substrate conversion. 
This sharp decrease in substrate conversion due to a small alter­
ation in pH has also been found in many of the above mentioned 
preparations. pH is known to have an effect on the ionisation of 
the substrate, its binding to the enzymic active site and on the 
binding of prosthetic groups, and a combination of these effects 
may be responsible for the influence of pH observed.
In investigating the time course of AA metabolism it was 
noticeable how rapidly substrate conversion proceeded in the first 
five minutes after the initiation of the reaction. Thereafter 
although substrate conversion continued it took 25 minutes to double 
the amount of product formed for both decidual and myométrial 
microsomes. This decrease in product formation after five minutes 
supports the work of Wallach and Daniels (1971) who found that PG 
synthesis by sheep seminal vesicle microsomes was only linear with 
respect to time for the first 6 minutes, thereafter the rate 
declining. They suggested that one or more reaction products of a 
fatty acid nature inhibited the enzyme and they claim it is a 
competitive inhibition as the enzyme can be reactivated if the 
microsomes were separated by centrifugation and added to fresh 
buffer. Uterine horns from non-pregnant rats have also been shown 
to produce maximal amounts of products in the first five minutes.
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which then declined, production was restarted if the horn was 
transferred to fresh buffer (Ishikawa and FuchA. 1978). They also 
concluded this inhibition was due to the accumulation of an 
inhibitor in the incubation medium.
It was demonstrated that there was no linear relationship 
between protein concentration of microsomes and product formation. 
Very similar results wete obtained by Wlodawer, Kindahl and Hamberg 
(1976) using microsomes of cow and guinea-pig non-pregnant uteri. 
They failed to correlate concentration of microsomes with quantity 
of PGs synthesized. This inhibition may be related to the reduction 
of PG synthesis as incubation time progresses.
When the influence of substrate concentration on PG synthesis 
by decidual and myométrial microsomes was investigated it was found 
that the PG synthetase complexes did not conform to classical 
enzyme kinetics. With decidual microsomes there was a marked 
inhibition of PG synthesis with increasing substrate concentration.
A similar inhibition also occurred in myométrial microsomes but was 
less well defined and was at a lower concentration. Substrate 
inhibition of PG synthesis has also been noted in bovine seminal 
vesicle microsomes (Yoshimoto, Ito and Tomita, 1970; Duvivier, Wolf 
and Heusghem, 1975) and rabbit kidney medulla microsomes 
(Schwartzman, Gafni and Raz, 1976). It has been suggested that 
substrate inhibition by fatty acids (such as AA) is caused by the 
detergent properties exerted by high concentrations of the fatty 
acids (Pande and Mead, 1968). However, this does not account for 
inhibition of the two uterine microsomal preparations occurring at 
different substrate concentrations. The common postulate for 
substrate inhibition is that the active site of the enzyme is 
crowded with substrate molecules competing to occupy it, so that no
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particular molecule can combine with all the binding groups of 
the active site. The result is that the binding groups are split 
between two or more substrate molecules. These multi-substrate 
complexes are rarely active as the substrate is usually not 
properly orientated (Walter, 1965). Substrate inhibition is a 
fairly common phenomenon, other examples are hydrolysis of urea by 
urease (Laidler and Hoare, 1949), hydrolysis of carbobenzoxyglycyl- 
L-tryptophan by carboxypeptidase (Lumry, Smith and Glanlz, 1951), 
and the reaction of ethanol and NAD"^ catalysed by alcohol dehydro­
genase, ethanol being the inhibitor (Harnes, Bronskill, Gurr and 
Wong, 1972). As the PG synthetase present in decidual and myo-? 
metrial microsomes was not a "classical" enzyme it was not possible
to calculate the K or V of these enzyme complexes, m m
At the time the preparation of an acetone-pentane powder was 
undertaken, the complete dependence of the PG synthetase in the 
decidual and myométrial microsomal preparations on hydroquinone was 
unknown. It is thought this contributed towards the unsuccessful 
result of this work, as hydroquinone was not used in the buffer while 
preparing the powder. A stable lyophylate of uterine PG synthetase 
from both decidual and myométrial microsomes using normal buffer 
containing hydroquinone has recently been prepared (Harrowing, 
personal communication).
Cofactors
It is notable that crude uterine homogenates synthesize predom­
inantly PG?2^ as estimated by bioassay (Vane and Williams, 1973). 
However, 6-oxo-PGF^^ has been shown to be the main product in 
homogenates of the pseudopregnant rat uterus (Fenwick, Jones, Naylor, 
Poyser and Wilson, 1977). PGFg^, PGEg and PGDg were also detected
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in the pseudopregnant rat uteri homogenates by Fenwick et al (1977). 
More recently in isolated pregnant rat uteri at term Phillips and 
Poyser (1979) found PGDg, 6-oxo-PGF^^ and TXB^ to be the major PG- 
like materials found with smaller quantities of PGEg and PGF^^.
There is then some agreement between the products produced by the 
microsomal preparation of rat uteri and other rat uteri preparations. 
The different proportions of products seen may possibly be due to 
the inevitable replacement of the natural cofactor by exogenous 
cofactors which may differentially activate components of the PG 
synthetase.
When investigating the influence of cofactors on PG-like product 
formation by decidual and myométrial microsomal suspensions the 
presence of hydroquinone in the buffer before resuspension of the 
microsomes was found to be essential for AA metabolism. This is a 
major difference from other PG synthetase preparations such as RSVM 
and kidney medulla microsomes which retain a high synthetic capacity 
in the absence of hydroquinone (Cottee et al, 1977; Yoshimoto al, 
1970). In non-pregnant uterine microsomes of cow and guinea-pig 
Wlodawer et al,(1976) found hydroquinone to be inhibitory in any 
concentration. The role of hydroquinone in PG synthesis is as yet 
undertermined. Pace-Asciak (1972) postulated that the anti-oxidant 
cofactors (e.g. noradrenaline and adrenaline) stimulate the PG 
synthetase complex by stabilising the enzyme in the active form. 
Another postulate is that hydroquinone, or a similar cofactor is 
required for the attachment of oxygen to the fatty acid (Yoshimoto 
et al, 1970). Smith and Lands (1971) postulated that phenolic 
cofactors are required to activate the PG synthetase before the 
initial oxygenation reaction. The simplest explanation for the 
above postulates is that hydroquinone is responsible for the
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reduction of one or more of the reactive groups at the active site 
of the cyclo-oxygenase component of the PG synthetase complex. The 
ability to continually reduce the vital group(s) at the active site 
may decrease with time and be due to insufficient hydroquinone as 
time progressed in a reduced form. However, it must be noted that 
increasing the concentration of hydroquinone above the optima does 
not increase the rate of PG synthesis, but inhibits it. So the, 
action must be more complex, possibly by group(s): at the active 
site binding minor.reaction products.
The inclusion of GSH, or L-cysteine although increasing PG 
synthesis were not essential for PG synthesis. If both were absent 
then there was only a third of the synthetic activity when both were 
present. L-cysteine is not commonly used as a cofactor. However,
GSH has a longstanding involvement with PG synthesis. It has been 
reported to stimulate PG biosynthesis by bovine seminal vesicles 
(Yoshimoto et al, 1970), sheep seminal vesicle microsomes (Samuelsson, 
1970), rat skin microsomes (Kingston and Greaves, 1976) and in 
several microsomal preparations of rabbit tissues (Tai, Tai and 
Hollander, 1976; Pong and Levine, 1976). There are two predominant 
postulates on the action of GSH. The first suggests that GSH is 
required for the reduction of the intermediate endoperoxides 
(Yoshimoto et al, 1970). Others also present evidence that it may 
specifically activate the endoperoxide isomerase component to 
catalyse the formation of PGEg, (Lands, Lee and Smith, 1971; Tai,
1976). The second postulate propounds that the function of the GSH 
is to cycle the electron donor (e.g. hydroquinone) back into the 
reduced state (Flower, Cheung and Cushman, 1973; Foss, Takeguchi,
Tai, and Sih, 1971). It was shown that unlike some PG synthetase 
complexes the proportions of the different products synthesized by
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decidual and myométrial microsomes were unaffected by the inclusion 
of thiol containing cofactors. This is unlike RSVM (Cottee et al,
1977) , rat skin microsomes (Kingston and Greaves, 1976) and bovine 
seminal vesicle microsomes (Foss et al, 1971) , where inclusion of 
GSH resulted in increased PGE^ synthesis at the expense of the 
other products, Also taking into account that hydroquinone in 
thiol-free buffer oxidises spontaneously (within 60 minutes at 0°C). 
The probable ■ mechanism employed by the thiol containing cofactors 
to stimulate both decidual and myométrial microsomal PG synthesis 
is the reduction of the anti-oxidant supplying the synthetase 
with fresh reducing equivalents.
The finding that EDTA increases PG synthesis by decidual and 
myométrial microsomes is in line with the findings of other workers 
(Ziboh, 1973; Pace-Asciak, Morawska, Coceani and Wolfe, 1968). This 
stimulation of PG synthesis is thought to be caused by the EDTA 
chelating metal ions such as zinc, cadmium and copper which have 
been shown to be inhibitory to PG synthetase (Nugteren et al, 1966). 
An alternative but less likely possibility is that the EDTA is 
chelating calcium. This would prevent phospholipase A^ located in 
the microsomal fraction (Luckner and Renz, 1975) from liberating 
AA from phospholipid present and diluting the radiolabelled AA 
(Bohman and Larsson, 1975). The phospholipase in the microsomal 
fraction is calcium dependent (Newkirk and Waite, 1973). However, 
there is evidence that the phospholipase A^ in human decidua and 
myometrium, possibly responsible for the release of uterine PGs, is 
contained in lysosomes, and is calcium independent (Akesson, 1975).
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Effects of Cofactors
In incubations using decidual and myométrial microsomal 
suspensions it was possible to replace hydroquinone with other 
anti-oxidants as is the case with other tissue homogenates (Sih, 
Takeguchi and Foss, 1970; Pace-Asciak, 1972; Sykes and Maddox, 1972). 
Of the cofactors tried it was found that histamine and L-tryptophan 
plus haemoglobin were poor replacements for hydroquinone although 
L-tryptophan and haemoglobin have been reported to effectively 
replace hydroquine using bovine seminal vesicles (IVJlyamoto £t al,
1974). This suggests that in the uterus at least L-tryptophan is 
not the endogenous cofactor, as it had been postulated to be for 
bovine seminal vesicular gland (Chan, Nagasawa, Takeguchi and Sih,
1975) . Histamine was also found to be a poor cofactor for tumour 
PG synthetase by Sykes and Maddox (1972). 5-Hydroxytryptamine was 
found to be the best replacement cofactor in decidual incubations 
producing a substrate conversion similar to that seen with hydro­
quinone. Adrenaline and noradrenaline were approximately half as 
effective as 5-hydroxytryptamine. A different pattern was seen 
with myométrial microsomes were 5-hydroxytryptamine, noradrenaline 
and adrenaline all proved to effect a higher substrate conversion, 
than did hydroquinone (although only noradrenaline caused a 
significant increase).
When comparing the molecular structure of the different mole­
cules it is notable that the poor cofactors histamine and L-tryptophan 
possess no phenolic hydroxyl group while the effective cofactors had 
at least one phenolic OH group^ Suggesting this group is a prerequi­
site for cofactor function. L-Ascorbic acid was included to 
stabilise the buffers containing adrenaline and noradrenaline.
When used as a replacement for hydroquinone in decidual microsomal
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incubations it proved more effective than histamine and one quarter 
as effective as hydroquinone. With myométrial microsomes it was 
approximately 0.75 times as effective as hydroquinone in stimulating 
PG synthesis. These results are perhaps not surprising as L-ascorbic 
acid is an anti-oxidant as is hydroquinone. But it may indicate 
that the myométrial PG synthetase is less selective in its cofactor 
requirements. However, there is evidence that in solution L-ascorbic 
acid is cyclic and has free hydroxyl groups which may provide some 
structural similarity with the phenolic biogenic amines which have 
been mentioned. As L-ascorbic acid proved so effective in stimulating 
AA metabolism by myométrial microsomes it is possible that the high 
synthesis seen using adrenaline and noradrenaline could be due to 
the fact that the buffer also contained L-ascorbic acid as an 
anti-oxidant. However, when L-ascorbic acid was included in 
incubations along with hydroquinone as the cofactor the L-ascorbic 
acid did not promote a further increase in PG synthesis over that 
seen with hydroquinone alone. This suggests that the high stimu­
lation seen in myométrial AA metabolism using adrenaline and nor­
adrenaline as cofactors is actually due to the presence of these 
compounds and not due to interference from L-ascorbic acid.
Apart from affecting overall product formation the substituted 
cofactors also affected the relative proportions of the products 
which were formed by the decidual microsomes. All the cofactors 
used to replace hydroquinone caused a significant increase in PGF^^. 
While 5-hydroxytryptamine and histamine caused a significant decrease 
in TXBg synthesis. In contrast there was no significant effect on 
the relative proportions of 6-oxo-PGF^^ PGEg synthesized by the 
myométrial microsomes. It has been found by Sykes and Maddox 
(1972) using tumour cell homogenates, and Sih et al (1970) using
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bovine seminal vesicle microsomes that adrenaline and 5-hydroxy­
tryptamine favoured the synthesis of PGF more than hydroquinone.
The presence of an endogenous cofactor may explain why PGF^^ 
is produced in smaller quantities in the microsomal suspension than 
in crude homogenates (Vane and Williams, 1973). There is no clear 
indication from this data whether one of the cofactors investigated 
is the natural cofactor. The catecholamines have been favoured in 
this role by Pace-Asciak (1972) and Sih ejt ^  (1970). This appears 
to be a real possibility in the uterus. The uterus has been shown 
to contain adrenaline and noradrenaline stored in chromaffin cells, 
which are independent of the nervous supply. 80% of the stored 
catecholamines is depleted soon after the onset of labour (Wurtman, 
Axelrod and Potter, 1964; Barnea and Schelesnyak, 1965). The fact 
that adrenaline and noradrenaline are not the best cofactors 
available for the decidual PG synthetase need not necessarily 
be important. The myometrium constitutes 80% of the uterus, the 
decidua only 4% (with the other 16% being myometrium lying under the 
placentae). Even though the decidua is more active than the 
myometrium it could only be equivalent to 15% of the myométrial 
contribution which must therefore supply the largest quantity of PGs, 
It may be that it is the type rather than the quantities of PGs 
synthesized by the decidua which is important.
Influence of Gestation on Uterine PG Synthesis
Studies on uterine PG synthesis during the early stages of 
pregnancy are hampered by two factors, firstly the small size of the 
uterus and hence the presence of an extremely small quantity of 
decidual tissue. Secondly, the low PG synthetic capacity of the
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uterus at this time. Thus investigations were limited to days 
13-22 of pregnancy. Non-pregnant myometrium was used for compar­
ison but again endometrial tissue was not investigated due to the 
small amounts present.
In both decidual and myométrial microsomes PG synthetic 
capacity increased as parturition approached. From days 14-19 
the myometrium produced considerably more PGs than the decidua 
while on days 20 and 21 their synthetic capacity was approximately 
the same. Maximum PG synthesis occurred on day 22 (expected day 
of delivery), with the decidual synthetic capacity more than 
double that of the myometrium which appeared to plateau on days 
19-22. The synthetic capacity of both microsomal preparations 
was considerably diminished one day post-partum.
What are the factors which account for this change in PG 
synthesizing capacity in the uterus? Uterine weight trebles 
between days 13 and 22 and it could be argued that although the 
total synthesizing capacity of the uterus alters, the activity per 
unit weight of remains the same. However, this is unlikely to 
account for the changes which were seen because between days 21 
and 22 of pregnancy uterine weight remains fairly constant but over 
this period there is a massive increase in decidual PG synthesizing 
capability. The changes seen would seem to indicate that there is 
a real increase in the activity of the PG synthetase complex in the 
uterus. Such studies do not preclude the possibility that in the 
whole uterus the availability of AA may be the limiting factor in 
PG synthesis. However, as microsomal preparations utilising 
exogenous substrate were used, no information was gained on this 
point.
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The changes observed may have been produced by the marked 
fluctuations in the plasma levels of sex hormones which occur 
towards the end of gestation. Plasma progesterone levels in the 
rat rise sharply before implantation and remain elevated through­
out most of gestation but decline sharply before parturition (see 
Fuchs, 1978) . However, oestrogen levels are low during gestation 
but rise sharply just before parturition (Fuchs, 1978). Data 
available suggests that the actions of these two hormones on the 
uterus may be antagonistic. For instance dosing pregnant sheep 
with progesterone delays parturition for as long as dosing is 
continued (Liggins et al, 1972), while in the pregnant rat there 
is little change in uterine PG output when dosed with progesterone. 
(Harney, Sneddon and Williams, 1974). The only direct effect 
of progesterone on PG synthesis in the uterus of goats and sheep 
is that progesterone withdrawal precedes the rise in PG levels in 
uterine venous plasma (Thorburn et al, 1972) and that progesterone 
has been shown to suppress the release of PGF^^ into uterine 
venous blood in sheep although tissue concentrations rise in a 
normal fashion (Mitchell and Flint, 1977) . While, Ham e^ al,
(1975) and Sharma and Garg (1977) found that the PG content of the 
non-pregnant uterus in ovariectomised rats could be increased by 
dosing with oestrogen, and that the PGE/PGF ratio was also altered. 
This increase was abolished if the oestrogen was co-administered 
with progesterone (Ham et al, 1975). Fenwick et ^  (1977) found 
that giving Tamoxifen (an anti-oestrogenic drug) to pregnant rats 
decreased the ability of uterine homogenates to synthesize PGs.
The above evidence indicates that oestrogen acts to stimulate 
uterine contractility and PG synthesis whereas progesterone may 
act as a brake on this process ("progesterone block" - Csapo,
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1956, 1975). The decline in progesterone levels at term allows 
oestrogen to 'activate' the PG synthestase and may influence the 
ratio of products synthesized. The stimulant effect of oestrogen 
on uterine PG synthesis in probably brought about by its action in 
increasing protein synthesis and hence uterine content of the 
synthetase enzyme (see Means and O'Malley, 1972). It is also 
possible that the increase in PG levels could be due to a decrease 
in PG catabolism as this can be influenced by steroids (Blackwell 
and Flower, 1976). However, in this study microsomal suspensions 
were used which had been demonstrated to be free of PG catabolising 
enzymes, and any PGs formed during preparation of the microsomes 
would be lost in the supernatant. This must support a real 
increase in PG synthetic capacity.
The proportions of PG-like products synthesized by the myo­
métrial microsomes were unchanged as pregnancy pr ogressed, 6-oxo- 
PGF^^ being the major product throughout. In contrast it was found 
that the proportions of products synthesized by decidual microsomes 
altered as parturition approached. Between days 13 and 20 6-oxo- 
PF^^ was the major decidual PG synthesized. PGEg became the major 
AA metabolite only on day 21-22 of pregnancy. Despite the fact 
that the synthetic capacity of the myometrium is only a third of 
that of the decidua, because there is so much more of it, 6-oxo- 
PGF^^ is the major PG synthesized by the uterine microsomes.
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The Inhibition of Decidual and Myométrial PG Synthesis by NSAlDs.
The results indicated that microsomal preparations of uterine 
PG synthetase are susceptible to inhibition by NSAIDs. This is not 
exceptional as NSAIDs have been shown to be potent inhibition of PG 
synthesis in many systems (Flower, 1974; Pong and Levine, 1976). In 
general the I.D.^^ values (that dose of NSAIDs which cause a 50% 
inhibition of PG synthesis) were lower for the myométrial 
microsomes than for the decidual microsomes. This difference is 
not surprising in view of the fact that the decidual microsomes have 
three times more synthetic activity than the myométrial microsomes. 
However, the difference is not as great as might be expected with 
the difference in synthetic capacity of the different microsomal 
preparation. There are several possible reasons for this. Firstly, 
substrate concentration can affect the I.D.^^ for particular 
inhibitor e.g. aspirin and indomethacin have a greater potency at 
low substrate concentrations compared to high concentrations 
(Cushman and Cheung, 1976). This is infact seen with the microsomal 
preparations used. With the myométrial PG synthetase the substrate 
concentration used was maximal whereas the decidual PG synthetase 
utilised a similar substrate concentration which was considerably 
below its maximum. These differences may have artifically reduced 
the differences between the two I.D.^^ values. Therefore, it is not 
really valid to compare actual I.D.^^^ obtained for the same drug 
using different synthetase preparations but it is still valid to 
compare the order of potency. The I.D.^^ values obtained for 
indomethacin and aspirin are comparable to those obtained with 
microsomes from rabbit kidney (Flower, 1974) and non-pregnant 
rabbit uterus (Pong and Levine, 1976). Aiken (1974) examined a 
number of NSAIDs for effects on motility of the rat pregnant uterus
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in vitro (where motility is related to PG output). From his results 
aspirin has a similar to that obtained in the present studies
but indomethacin was found to be more potent. This may be a further 
reflection of the influence of substrate concentration, as using 
uterine strips PG synthesis is dependent on endogenous substrate 
concentrations.
The relative potency of drugs was expressed relative to TYA 
because TYA is an acetylated substrate analogue of AA and therefore 
the closest inhibitor in structure to A.A. It reacts with the 
active site of the cyclo-oxygenase (Downing, Ahern and Bachta, 1970) 
and its inhibitory activity consists of an initial concentration- 
dependent effect (Ahern and Downing, 1970) and a time-dependent 
irreversible inhibition (Lands, Le Tellier, Rome and Vanderhoek, 1973) 
similar to many NSAIDs (Flower, 1974). The rank order of potency 
revealed that flurbiprofen was the most potent inhibitor studied.
This finding is in agreement with that of Crook and Collins (1976) 
who also found this drug most potent in inhibiting PG synthesis by 
microsomes of rheumatoid synovia. There was no difference in the 
rank order between the decidual and myométrial preparations.
Tranylcypromine has been included under the catch-all heading 
of NSAIDs though it is really a tricyclic anti-depressant. This drug 
has been shown to inhibit PG synthesis in cell free homogenates of 
guinea-pig lung (Lee, 1974) and to reduce motility of the pregnant 
rat uterus ^  vitro (Tothill, Bamford and Draper, 1971). Furthermore, 
tranylcypromine has recently been reported to be a selective inhib­
itor of prostacyclin synthetase (Gryglewski e^ al, 1976). When 
investigating the effects of inhibitors which act at more distal sites 
than the cyclo-oxygenase one may expect to see altered ratios of 
products under the influence of such drugs, as endoperoxides will still
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be produced and would be free to be transformed by other enzymes such
as isomerase, reductase or thromboxane synthetase. However, this
was not seen. In the case of the decidua tranylcypromine inhibited
production of all products to an equal extent, and rather surprisingly
the I.D.^gValue for the myométrial microsomes was higher than that
seen with the decidual preparation. Again a possible explanation
of this discrepancy is that the activity of the prostacyclin
synthetase in the myométrial preparation was higher than that in
the decidua. This is certainly backed up by the amounts of 6-oxo-
PGF, produced, la
Metopirone is also a drug which is not an NSAID but on inhibitor
of corticosteroid biosynthesis which has been reported to inhibit
PG synthetase (Parnham and Sneddon, 1975). The drug was also reported
to alter the ratios of PGs synthesized in uterine homogenates, PGEg
formation being inhibited whereas an apparent increase in PGF^^
synthesis was noted. As the assay system used did not differentiate
between PGE„ and 6-oxo-PGF, it was possible that 5-oxo-PGF,2 la la
synthesis was being selectively inhibited and allowing endoperoxides 
to be diverted for conversion by the reductase enzyme so increasing 
PGEg production. However, with decidual and myométrial PG 
synthetase metopirone was a very poor inhibitor and had no detect­
able effect on the ratio of products synthesized by either 
preparation. As the work of Parnham and Sneddon (1975) was carried 
out using crude homogenates it may be:that metopirone did not 
act directly on the PG synthetase, that it requires a factor 
present in crude homogenates in order to exert its inhibitory effect 
and may only act at low concehtrations of AA, as found endogenously.
160
Several previous studies have demonstrated in animals that it 
is possible to affect uterine motility with NSAIDs both in vitro 
and vivo (Aiken, 1972; Aiken, 1974; Chester e^ al, 1972;
Hertelendy, 1973; Novy et al, 1974; Vane and Williams, 1973).
These results have clinical relevance because NSAIDs have subse­
quently been used to inhibit uterine contractions associated with 
premature labour (Zuckerman £t al, 1974) and dysmenorrhoea 
(Lundstrom and Green, 1978). The isolated rat uterus in particular 
appears to provide a good model for studying the gross effects of 
these drugs (Williams et al, 1974). However, difficulties arise 
when trying to accurately assess the potencies of a variety of 
NSAIDs using this preparation (Lewis, Cottney and Sugrue, 1975).
The use of a stable uterine microsome preparation overcomes these 
difficulties and allows accurate assessment of inhibitory potency.
The fact that flurbiprofen is at least five times more potent than 
indomethacin suggests that this drug may be more useful to the 
obstetrician than indomethacin.
Microsomes of Placentae and MUP and the Inhibition of PG Synthesis 
by Microsomal Supernatants
The MUP was found to have a very low PG synthesizing capacity. 
This was surprising as the MUP is an integral part of the myometrium 
which as shown previously has considerable PG synthesizing capability. 
Since a microsomal preparation was used and exogenous substrate was 
added, the low synthetic capacity of the MUP could not be due to a 
lack of substrate. It was also found that placental microsomes 
prepared from placentae on day 22 of pregnancy were also a poor 
source of PG synthetase. This agrees with the findings of Carminati,
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Lüzzani, Saffientini and Lerner (1975) who used crude homogenates 
of rat placentae taken between days 8-21 of pregnancy. It is worth 
noting that human placental microsomes also have a low PG synthetic 
capability when taken at term (Duchesne, Thaler-Dao and Crashes de 
Paulet, 1978).
There has been no published explanation for this low PG synthetic 
activity. However, the low synthetic activity of the MUP and the 
placentae may be linked as they are in direct contact (decidua eroded 
in this region). One plausible hypothesis for such low synthesis is 
that there is an inhibitor of some type present in the placenta and 
that this inhibitor infiltrates into the MUP. In this respect it is 
of interest that the microsomal supernatants from decidual, myométrial 
and placental microsomes and non-pregnant rat myometrium contain a 
factor(s) which inhibited PG synthesis. This factor(s) was heat- 
labile and inhibited PG synthesis in a dose-dependant manner. The 
inhibitory activity could not be removed by passing the supernatants 
down silicic acid columns (which removed 90% of the labelled AA 
tracer). This indicates that the inhibition was not simply due to 
a dilution of labelled AA by endogenous substrate contained in the 
supernatant. In support of this was the finding that boiling AA for 
1-2 minutes did not destroy the substrate and reduce subsequent PG 
synthesis by decidual and myométrial microsomes. Another possibility 
was that the uterine microsomal pellets contain substantial amounts 
of phospholipid and if phospholipase A^ was present in the placental 
microsomal supernatant this would release endogenous AA. The phos­
pholipase A^ was originally thought to be membrane phospholipase and 
therefore, dependent on calcium ions, the presence of which should 
be minimised by the inclusion of EDTA in the buffer (Bohman and 
Larsson, 1975). However, in human decidua and myometrium
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phospholipase is of lysosomal origin and is inhibited by calcium 
ions (Akesson, 1975). It is possible this is also present in rat 
decidua, myometrium and placenta, and would be found in the supernatant 
(which all contained inhibitory activity). This in addition to the 
resuspended microsomes the phospholipase A^ in the supernatant would 
liberate endogenous substrate and so dilute the radiolabelled AA.
This mechanism of inhibition is unlikely however, as uterine micro­
somes prepared in the presence of mepacrine, a phospholipase A^ 
inhibitor did not affect inhibitory potency (Harrowing and Williams, 
1979). In addition washing uterine microsomes with an acetone/ 
pentane mixture, removed the phospholipid, still resulted in the same 
degree of inhibition as untreated microsomes. If release of endo­
genous substrate was responsible for the inhibitory effect, it would 
have been expected that the inhibitory potency of the supernatant 
would have decreased (Harrowing and Williams, 1979). The microsomal 
supernatant is also known to contain the enzymes which catabolise 
PGs. The probability that PGs synthesized were being metabolised by 
such enzymes which would evidence itself as an inhibition was 
eliminated by showing that incubation of the supernatants with
radiolabelled PGE, or PGF_ did not cause noticable breakdown of 1 2a
these compounds.
The placental microsomal supernatant also inhibited AA meta­
bolism by RSVM showing the inhibitory action was not restricted to 
uterine PG synthetase. The potency of the supernatant however, on 
RSVM was not as great as with uterine PG synthetase preparations.
This result would be expected as the RSVM contains a more active 
synthetase.
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The site of action of the placental inhibitor appears to be
I ' . :  I
the cyclo-oxygenase, as all products of AA metabolism were reduced, 
with no change in the ratio of products synthesized.
Similar findings have been reported for the supernatants of 
several other tissues; bovine seminal vesicles (Takeguchi, Kohno 
and Sih, 1971), human skin (Ziboh, 1973), guinea-pig lung (Parkes 
and Eling, 1974), rabbit kidney medulla (Rose and Collins, 1974; 
Schwartzman, Gafni and Raz, 1976; Tai, Tai and Hollander, 1976), 
and non-pregnant uteri of cows and guinea-pigs (Wlodawer,
Kindahl and Hamberg, 1976). In addition to finding the inhibitor 
to be heat sensitive, Takeguchi et a^ (1971); Rose and Collins (1974) 
and Wlodawer et al, (1976), all found their respective inhibitors 
to inhibit in a dose-dependant manner. In these studies the 
possibility of dilution of labelled substrate by endogenous AA 
leading to an apparent inhibition was not checked except in the 
experiments of Wlodawer et a^ (1976) who estimated AA conversion 
by oxygen uptake on oxygen electrode which eliminated this possibility.
The evidence presented in this study eliminates the possibility 
that the inhibitory activity was due to simple dilution of labelled 
substrate. It is then tempting to speculate that the inhibitor is 
a proteinaceousmolecule, as it is heat labile as were others 
(Takeguchi e^ al, 1971; Tai e^ al, 1976). The inhibitor could have 
two possible sources of origin, one is the actual cells of the tissue; 
the other from trapped blood elements. In this context it is worth 
mentioning that White and Glassman (1976) found that the addition of 
platelet-poor plasma to washed platelets caused a strong inhibition 
of PG synthesis from radio-labelled AA. They concluded it was due to 
the substrate binding onto albumin. More recently Saeed,
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MacDonald-Gibson, Cuthbert, Copas, Schneider, Gardiner, Butt and 
Collier (1977) reported the presence of an endogenous inhibitor 
of PG synthesis which is a protein, as it is associated with the 
a-globulin fraction of plasma. If the inhibitor is present in the 
plasma, which infiltrates virtually every organ in the body it 
would explain why it can be found in the microsomal supernatants 
of so many different tissues.
There are conceivably two possible mechanisms by which such an 
inhibitor could act. The first is that the inhibitor is a large 
protein and the substrate is bound to it, therefore denying it to 
the PG synthetase. Serum albumins have been shown to do this (Tai 
et al, 1976; White and Glassman, 1976). The second mechanism is that 
the inhibitor blocks the access of substrate to the active site of 
the cyclo-oxygenase, presumably by reacting with one or more of the 
active groups. Evidence against the first mechanism has been 
presented by Harrowing and Williams (1979) who showed that 
preincubating the microsomal supernatant with the substrate did not 
increase the amount of inhibition seen and argues against the 
inhibitor binding the substrate.
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General Discussion
Although there is strong evidence that uterine PGs play an 
active role in parturition (Aiken, 1972; Chester et al, 1972; 
Hertelendy, 1973; Lewis and Schulman, 1973; Novy et al, 1974;
Vane and Williams, 1973) many of these studies have relied upon 
the use of PG synthetase inhibitors such as indomethacin. This 
type of experiment does not allow any conclusion as to which of 
the AA metabolites played a role in regulating uterine motility.
The experiments reported here have shown some interesting facts, 
firstly the myometrium produces large amounts of 6-oxo-PGF^^ and 
the decidua a mixture of PGs. The oxytocic effects of PGE^ and 
PGFg^ have been well documented, however the question arises, 
if decidual PGs play a role in governing uterine motility how do 
they pass from the decidua to the myometrium? A process of 
diffusion would have to be invoked and as this would not proceed 
preferentially in either direction then much of the decidual PGs 
would be expected to diffuse intra-luminally and pass into the 
amniotic fluid. Thus the actual concentration reaching the 
myometrium would be considerably reduced. It is a much more 
attrative hypothesis that the myometrium itself produces a substance 
which governs its contractility. As yet very little is known about 
the actions of prostacyclin on the reproductive organs. It does 
appear that prostacyclin is a weaker oxytocic than either PGE^ 
or PGFg^ (Omini, Moncada and Vane, 1977; Williams, El Tahir and 
Marcinkiewicz, 1979). However, prostacyclin in subthreshold doses 
will potentiate oxytocic-induced uterine contractions (Williams 
et al, 1979). This could mean that the increase in myométrial 
prostacyclin formation during the last days of pregnancy (Williams, 
Dembinska-Kiec, Zmuda and Gryglewski, 1978) progressively sensitizes 
the myometrium to circulating oxytocin (Williams et al, 1979).
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Recently Omini, Falco, Passargiklian, Fano and Benti (1979) 
have demonstrated that prostacyclin lowers uterine tone and reduces 
spontaneous contractility in isolated strips of human pregnant 
myometrium. They postulate that prostacyclin may modulate uterine 
motility by this action. But a conflicting report has also recently 
been published showing that prostacyclin has an oxytocic effect on 
the human pregnant myometrium (Wilhelmson, Lindblom, Hamberger, 
Samsioe, Hammarstrom, Wiqvist , and Samuelsson, 1979) and so at the 
present stage it is difficult to say whether prostacyclin has mixed 
actions in the human myometrium. The discrepancy between the 
different groups could be due to the different areas of the uterus 
from which the tissue samples were taken. There is also the 
possibility as seen in the rat that as prostacyclin is a weaker 
oxytocic than PGs it may be produced in order to dilute the effects 
of the more potent oxytocics produced in the decidua. But as to 
why one should see a large increase in myométrial prostacyclin 
formation at term (Williams et al, 1978) along with a large increase 
in prostaglandin synthesis remains to be elucidated.
Apart from an active role at the time of parturition in influen­
cing contractility it must be in mind that 5 - o x o - P G F a n d  hence by 
inference prostacyclin is the major product of the decidua and the 
myometrium between days 13-22 of pregnancy when the foetus is rapidly 
developing. It is possible that prostacyclin so produced may play 
other roles. One suggested by Williams et ^  (1978) was that 
myométrial prostacyclin may help to maintain an adequate uterine 
blood supply to the developing foetus as prostacyclin has been shown 
to be a potent vasodilator in the rat (Armstrong, Lattimer, Moncada 
and Vane, 1978).
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It is possible that the low synthetic activity seen with 
microsomal preparations of MUP and placentae could well be due to 
the action of an inhibitor. A possible role for an endogenous 
inhibitor is not hard to find. As prostacyclin is a potent vaso­
dilator (Armstrong et al, 1978) suppression of its production at 
the site of placental attachement would be logical as blood loss 
after placental detachment would be reduced. A further function 
would be to suppress localised contrations beneath the placentae, 
thus preventing premature detachment. The finding that similar 
inhibitors are present in tissues other than the placenta indicates 
that they could play a role in local control of PG synthesis 
throughout the body.
Conclusions
1. Rat uteri on day 22 were separated into constituent tissues, 
decidua and myometrium. The AA metabolism by microsomes 
from these tissues was studied using a radiometric assay. 
Products were separated and identified using various TLC 
procedures.
2. The major AA metabolite synthesized by myométrial microsomes
was 6-oxo-PGF, . The decidual microsomes were found to la
synthesize PGEg, 6 - o x o - P G F P G F ^ ^ ,  PGDg and TXB^. PGEg was 
the major product,
3. Optimal incubation conditions for decidual and myométrial PG 
synthetase are similar but not identical to other PG synthetase 
systems. There are also differences between decidual and 
myométrial PG synthetases, particularly in regard to synthetic 
capacity and optimal substrate concentration.
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4. PG synthesis by decidual and myométrial microsomes is 
absolutely dependent on the inclusion of an anti-oxidant in 
the incubation medium.
5. The ratio of PG-like products synthesized by either decidual 
or myométrial microsomes was unaffected by the presence or 
absence of thiol containing cofactors (e.g. GSH and L-cysteine). 
However, overall synthesis was decreased in the absence of 
thiol containing cofactors in both preparations.
6 . Substitution of adrenaline, noradrenaline, 5-hydroxytryptamine, 
histamine and L-ascorbic acid for hydroquinone as a cofactor 
significantly increased PGFg^ synthesis in decidual microsomes, 
but 5-hydroxytryptamine was the only cofactor which was as 
effective as hydroquinone in stimulating total PG production. 
Substitution of hydroquinone by adrenaline, noradrenaline or
5-hydroxytryptamine led to an overall stimulation of PG 
synthesis in myométrial microsomes, but did not affect the 
ratio of products formed.
7. PG synthesis by decidual and myométrial microsomes was inhibited
by a variety of NSAIDs. The most potent of these was found
to be flurbiprofen.
8 l . A s pregnancy progresses the PG synthesizing capacity increases
in both decidual and myométrial microsomes. Maximum synthetic
capacity occurs on day 22 of pregnancy, day of delivery, and 
declines sharply within 24 hours post-parturn.
9. There is little PG synthetic activity in microsomal preparations 
of MUP and placenta taken from day 22 rat uteri.
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10. An inhibitory factor(s) is present in the microsomal super­
natant fraction of microsomal preparations of decidua, myometrium 
and placenta. This factor(s) is heat labile, inhibits PG 
synthesis in a dose-dependent fashion and acts at the cyclo- 
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Differential prostaglandin  
production by microsomal fractions 
of rat pregnant uterus
I. D O W N IN G  & K.I. W ILLIA IV IS
P harm aco log y Group, S ch o o l o f P harm acy  and  
Pharmacology. University of Bath. B ath B A 2 7A Y
Crude homogenates o f decidual tissue from rat 
pregnant uteri synthesize prostaglandin (PC) F as 
estimated by parallel bioassay (Williams, Sneddon & 
Harney. 1974). As recent work has shown the 
increasing complexity o f arachidonic acid metabolism 
we have developed a radiometric assay to allow more 
detailed analysis of products formed by the uterus.
Pregnant rats were killed (day 22 o f pregnancy) and 
20% homogenates o f deciduum and myometrium 
prepared in Tris/acetate bulTer (pH 8) containing 
hydroquinone 0.5 mM and reduced glutathione 2 mM. 
Microsomes were prepared by ultracentrifugation and 
samples incubated with 1 ml aliquots of buffer 
containing arachidonic acid (99 nmol) and [ ‘■‘Cj- 
arachidonic acid (3.5 nmol) for 30 min at 37°C. Pilot 
experiments indicated these conditions were optimal 
for decidual tissue with regard to substrate and co­
factor concentrations, pH and incubation time. 
Samples boiled before incubation served as controls. 
After solvent extraction residues were subjected to 
thin-layer chromatography (TLC ) using the solvent 
chloroform 90: methanol 9: acetic acid 1 : water 0.65 
by volume. The radioactivity in consecutive 0.5 cm 
bands o f each zone was then estimated by liquid 
scintillation counting. Authentic PGF,^, POE., ['■'Cl-
6 - 0 X 0  POP,g (prepared as described by Cottee. 
Flower, Moncada, Salmon &  Vane, 1977) and 
arachidonic acid were used as markers.
With decidual microsomes 23% o f radioactivity on 
the TLC  plate v/as converted to products other than 
monohydroxy acids (range 14-50%, 15 experiments). 
50% of this radioactivity had an Rp value similar to 
PGEz, 25% ran as PGD^ while 20% had a mobility 
equivalent to PGFj„. Myométrial substrate conversion 
was lower, 6% (range 2-15% , 15 experiments) and all 
the radioactivity was located in the PGE; zone. 
However, in this solvent system PGE^ and 6-oxo PGF,„ 
have similar Rp values. Therefore the zones o f radio­
activity corresponding to PGP? were removed, eluted 
and rechromatographed using solvent systems devised 
to separate these two substances (Cottee et ai, 1977). 
Using these TLC  systems we found that approximately 
12% o f radioactivity in the decidual PGE zone behaved 
as 6 - 0 X 0  PGF(^ and 70% as PGE;. However 84% of 
myométrial radioactivity appeared to be 6-oxo PGF,^ 
and only 6% PGE;.
Thus decidual microsomes produce PGE, as the 
major product whereas myométrial preparations 
synthesize predominantly 6-oxo PGF,„. Further 
investigation is needed to determine whether this 
myométrial PG production plays any part in 
regulating uterine function during pregnancy.
We thank the Wellcome Trust for a grant.
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ABSTRACT
The preparation of a microsomal fraction from the decidual tissue 
of pregnant rat uteri is described. Incubation of such microsomes with 
a mixture of radiclabelled and cold arachidonic acid (51 uK) plus co- 
factors resulted in a 30% substrate conversion. Products were resolved 
into four peaks (A,B,C and D) by thin-layer chromatography. Combined 
gas-liquid chromatography-mass spectrometry and further thin-layer 
chrcm itography identified the products as ?GF 2 “ (A); thromboxane 5; (B> ; 
a mixture of 6-0X0 PGF i “ and PGE; (0); PCD; and PGE 2 (D). PGE 2 was the 
major product.
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INTRODUCTION
Many experimental findings suggest that prostaglandins (PGs) play 
an important role in parturition. Williams and Vane /_ \ J  have reviewed 
the evidence favouring PG involvement. Many experiments have depended 
upon the use of non-steroidal anti-inflammatory drugs as PG synthetase 
inhibitors. For instance indomethacin blocks both the spontaneous _  _
contractions and PG release from the rat pregnant ute^rus in vitro / 2,3 / 
and delays parturition and prolongs labour in rats /_ 3_7. As a result ~  
of such findings indomethacin has been used clinically as a rationa_l 
treatr.ent for innibiting uterine contractions in premature labour / 4_/. 
Despite the clinical ir.pcrtance of blocking uterine ?G synthesis little 
is known of the PG synthesizing system in the pregnant uterus. As a 
rirst step in such a study we have used a microsomal preparation from the 
decidual tissue of the pregnant rat uterus as our source of PG synthetase. 
This study desc-ibes the products which are formed when this enzyme 
system is incuba ted with arachidonic acid.
METHODS
Female rats (CFY strain) were killed on day 22 of pregnancy 
(expected day cf delivery). Decidual tissue was separated froo the 
myometrial, by scraping. A 20% I / ) decidual horaogenate was prepared 
in ice-cold 0.1 M Tris/acetate buffer (pH8) containing sucrose (0.2SM), 
EDTA (ImM; , hydroquinone (0.5 =lM) , L-cysteine (Lm.M) and reduced 
glutathione (2m.M) using an Ultra-Turrax homcgcniser. The homcgenate vas
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ccM'.Lrifogcd at 3000 x g for 30 minute j and (lu; supur natant rocr.r.ti, ifiigrd 
at lO0,OCO X g for CO uiinutcr;. Tim microncma 1 .pcllat was icsuspcralod in 
buffer by ul I ra non i cation (20>t'iz, 1 CoW for 15 seconds) to give a protein 
coriccntraticn of 1-3 r.g/;nl . 1 nl alrciuots of the suspension were
jrioubated for 30 lidnulos at 27^'C u i t ' r . In 1 of buffer containiny arachi- 
donic acid (F9 r.noles) and / 1- ' / arachidonic acid (200 r.Cj ) giving
a total subs trite concentrât i on of Sl;.n. the reaction was terminated
with 0.25:01 of 2M citric acid. Sa-T.plos boi led for CO seconds bafoic 
incui.iaticn acted as controls. Acidified sai.r.>los were extracted twice 
with 2 volumes c£ c-'her. In the rrajority of cases ti.e combined ext; acts 
we r c dried using a rdf.-1) aus •ncOinir. su'i phatc before cvaj.'ora tion under 
nitrogen and i.-.a.c <li dtc addition of of chloroform. Each sample was
then arp 1 i cd te i.hin-layer chrcmit sgr.aohic CE.'-C) plates (silica nel G,
0.25 i:Ji, thi ckness) lolicv.ed by au tl.onti c I'GF;.'i, PC dr and arachidonic 
acid, in rcac- c-xpcri.i-mts PGOn, PGA and PC3 ware also applied, 'jhe 
plates werc ceveloprd in c.nlorc'fcr;r,, metl.anol, acetic ccid and v.-.it er 
(90: 5:1: 0. 65) to 15 cm. P.fter drying authentic .'rmkc-rs ware vi sea) i sod 
with icxii.ne vapour. Areas of radicactivity v.sie -;h'I. ctcd using a 
Flerthjld T1X3 scar.ncr. Eac/i tone was t net, di viced into 0.5cm h ir.dr which 
were scraped off and the radioactivity eluted w:ih ltd of net)nmol.
5'sd of scintillant (0.51 PPG and 0.035 dine t.hyl PCI CP in toluene) v;eie 
added and radioactivity doterninei by liquid scintillation counting. 
Absolute .ictivity (d.p.m.) was calculated by tlio coumor using a j ic- 
progran.ocd cuc-r.c.h correction curve based on a chan.nel s ratio.
In several experi nents the C and D peaks (see rc su Ils) were
scraped off, eluted with i.vethanol and resolved in otiier Ti.C systems.
Peak C was resolved in (a; the organic (upper) pi.ise of ethyl acota'e 
iso-octane, acetic acid, water (11:5:2:10) cn plutcs described c=b:<ve or 
(b) chloroform, n.ctiianol, acct ic acid (GO: 10: 10) on T.hC plates i:ioreg- 
na ted wit); 51 silver nitrate. /Onese systems wore devised to separate 
PGE; and 6-oxo PCF-, « / 5 /. Peak D v/as r ccliroi.'i tc:j rc.phod using et)icr, 
t'othanol, acetic acid (Oo: 1 :2) which .separates • C-. ar.d PCD/ 0 /. In 
those expcrime.its PGP? ° , PGE?, PCD? and /_ 1-‘‘C_/ G-o:to EGFj « were 
used as markers.
The pror-aratipn of 6-oxo IGFj has recently Icon described / 5 7. 
ICO nCi of / 1-‘“C /  arachidonic acid were incueatod with 10 rg of ram 
Ctcii.nal vesicle i: icrcsoa.es in l_r.il of Tris buffer [ H7.4 for 15 riir.utes at 
loora tcfipc-rcture. 'the / 1-‘‘'C_/ 6-oxo PC?i >x was sepatatod by Ti.C u-'ing 
the systeiis described above.
Cas-I iquid Cltrcnato-iraphy and Mass Spectrrmetrv (CT.C-MS)
A [«repar.iti'/e synthesis usir.q 30 ig. cf decidual r.icrocon.is war. 
carried cut ( i r.cubi ted in G :: 5 r.g a counts as d .scr i bc-d.) . ter TI.C 
the zones ccnt.iining rr.d icac ci vi cy v.’zce detecceu by scanning, scraccd 
off and eluted wit): zeeb.i.nol. Fro t e ten sa:::ple the r.ethyl es t̂  r, 
nethyl o.xioc, tr leathyl silyl et.n̂ r̂ was prepare. Prcaucts were iden­
tified 1 y C-IG-P.G and qu i.nt. tac.d ago lost tl.e dirivative of authentic 
PGF? a. Pull d It a i Is of the GbC-:'3 ofccodurc hav.i been pibli'had / 7 /.
P.Ei.ULTS
The distribution of radioactivity cn a 'fli? plate after incubation 
of decldu.al micro :omcs wiih labcllcl arachidonic acid is ch,.tw;i
«î'i N()vi7.';;nu 977 voi.. i -̂ no.




D IS T A N C E  FHOM O R IU J X  (CM)
Figure 1. Distribution cf radioactivity on a TLC elate after incubation 
of decidual tr.icro3cn:es with radiolabelled arachidonic acid. Xet d.p.r.. 
indicates cast minus her led con tard value. The broker, line at t;-.e solvent 
front indicates nore radioactivity present in the coiled control zones.
in Figure 1. Four distinct peaks were seen which were not present in 
boiled control samples. Peak A had an R value similar to authentic 
?GF;“ (0.25) with peaJ< 3 running slightiv higher j_R_ 0.42). Peak C had
a r.cbility equivalent to authentic PGE? [_ C.56_/.‘ The least polar
peak D had an of 0.51. Substrate conversion was 231 in this experiiie.nt 
and a nean cf 20% (range 15-55) in 17 experiments. Product formation 
(s'ubstrate converted) was taken as the radioactivity between peaks A and 
D expressed as % of the total activity recovered from the plate (after 
subtraction cf boiled control values). This figure thus excludes 
rone hydroxy fatty acids produced which run close to aracliidonic acid in 
this system. PGA and PG3 were not included as these substances have R^ 
values of 0.30-0.85 in this system and negligible amounts of these 
products were noted.
In Figure 1 the contribution of each peak to the total product 
was as follows: peak A 10%; peak 3 13%; peak C 50%; peak D 27%. Subsequent 
cliromatography of peak C in the first solvent system indicated the 
presence of two products witii values corresponding to 6-oxo PGF; °
(Rp 0 .1 2 )  and PGE; (R^ 0 . 2 4 ) .  T h is  was co n firm e d  us ing  tlie  second s o lv e n t
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system with nitrated plates PGE? 0.44), 6-oxo PGF. & 0.70), In
these experiments the zone corresponding to PGE; contained the majority
of radioactivity, 74% (range 64-S5 n = 6) ,- 9% (range 4-16 n = 6) of th.e
label had a mobility similar to 6-oxo PGF;
Peak D was also resolved into two peaks with mobilities equivalent
to PGE; (R^ 0.16) and PCD; (R„ 0.42.) The two products were present in
similar quantities, PGE zone o3% (range 2 /-49 n = 6) ana ?GD zone 4i% 
(range 31-55 n = 6).
GLC-.MS was used to analyse the contents of the four peaks. Peak A 
contained th.e major ions associated with PGF; = and constituted 11% oi 
the estimated product. Peak 3 was identified as thrcmnoxane B; (3%).
Peak C contained the major ions of 6-oxo PGF] « (12%) and PGE; (£9.5%). 
Peak D contained PGE? (4.5%). No PGE, was detected in the extract.
EISCÜFSICN
These results confirm earlier findings whicii indicated that 
de'-icnal tissue from th£ ptjognant rat uterus at term has a high PG 
synthesizing capacity / 3_/. Chromarcgraphic procedures indicated the 
presence of five products with mobilities similar to PGE;, PGD;, PGF; « 
6 -0 X0  PGF] «■ a.nd thrombcxane 3;. Subsequent GEC-MS ccnfirr.ed the 
presence cf all the products except PGE;. The relative proportions of 
the substances estimated by tne two .methods agreed well taking into 
account tn..t no corrocticr. for loss was made through the deriv.itiia:ion 
prorecure for GIC-MS. Also quantitation of all products against PCF; - 
is not ideal but was used due to lack of ar.t.hencic 6-oxo PGF] - and 
thromboxane 3 ; . The reason for the lack of major ions associated with 
PGD; is unclear (the derivative of PGD; was s'ubject.ed to GEC-XS and a 
satisfactory spectra obtained). The GLC-XS result however is from only 
one experiment, using TLC procedures a peak with an R^ similar to PGD; 
is seen co.tsis tent! y . T'ne presence of PGE; in the D peak is probably 
due to overlapping caused by inadequate separation of PGE and PCD by 
this solvent system.
Crude uterine homogenates synthesize predominantly PGF;®as 
estimated by bioassay l_ 2_J whereas the microsomal preparations 
produced PCS; in the largest amounts. This difference is not accounted 
for by co-factor additions to the .microsomes as incubations without 
glutathione did not affect substrate conversion whereas no synthesis 
tcck place in the absence of hydroquinone (unpublished cbservations).
The factors governing the formation cf individual PGs by the uterus is 
obviously complex as under the incu))ation £onditions used myométrial 
micrcscT.es produce mainly 6-oxo PGF] ® /_ 9_/: this is a_lso_the major 
product of homogenates of pseudopregnant rat uterus /_ 10_/.
6 -0 X 0  PGF, ® and thrcmbcxano 3; synthesized by decidual microsotr.es 
are the stable products formed from _the unstable prostacyclin (PGig ) and 
thrortbcxane A; respectively [_ 11,12_/. vrnether these biologically 
active intermediates or their end nroducts exert.any actions in the 
pregnant uterus remains to be elucidated. Further experiments are in 
progress to investigate the factors controlling arachidonic acid 
metabolism and to determine the relative contributions of the products 
to uterine function during pregnancy.
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